BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Baffy G. Kupffer cells in non-alcoholic fatty liver disease: the emerging view. J Hepatol. 2009;51:212-223. [PMID: 19447517 DOI: 10.1016/j.jhep.2009.03.008] [Cited by in Crossref: 300] [Cited by in F6Publishing: 299] [Article Influence: 23.1] [Reference Citation Analysis]
Number Citing Articles
1 Cheong H, Lee SS, Lee JS, Kim J, Kim SW, Lee WJ. Phagocytic function of Kupffer cells in mouse nonalcoholic fatty liver disease models: Evaluation with superparamagnetic iron oxide. J Magn Reson Imaging. 2015;41:1218-1227. [PMID: 24916329 DOI: 10.1002/jmri.24674] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
2 Arslan N. Obesity, fatty liver disease and intestinal microbiota. World J Gastroenterol 2014; 20(44): 16452-16463 [PMID: 25469013 DOI: 10.3748/wjg.v20.i44.16452] [Cited by in CrossRef: 92] [Cited by in F6Publishing: 79] [Article Influence: 11.5] [Reference Citation Analysis]
3 Du X, Wu Z, Xu Y, Liu Y, Liu W, Wang T, Li C, Zhang C, Yi F, Gao L, Liang X, Ma C. Increased Tim-3 expression alleviates liver injury by regulating macrophage activation in MCD-induced NASH mice. Cell Mol Immunol 2019;16:878-86. [PMID: 29735977 DOI: 10.1038/s41423-018-0032-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
4 Tarasenko TN, McGuire PJ. The liver is a metabolic and immunologic organ: A reconsideration of metabolic decompensation due to infection in inborn errors of metabolism (IEM). Mol Genet Metab 2017;121:283-8. [PMID: 28666653 DOI: 10.1016/j.ymgme.2017.06.010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
5 Wang Y, Ziogas DC, Biddinger S, Kokkotou E. You deserve what you eat: lessons learned from the study of the melanin-concentrating hormone (MCH)-deficient mice. Gut 2010;59:1625-34. [PMID: 20966023 DOI: 10.1136/gut.2010.210526] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
6 Lin P, Lu J, Wang Y, Gu W, Yu J, Zhao R. Naturally Occurring Stilbenoid TSG Reverses Non-Alcoholic Fatty Liver Diseases via Gut-Liver Axis. PLoS One 2015;10:e0140346. [PMID: 26474417 DOI: 10.1371/journal.pone.0140346] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
7 Lewis JR, Mohanty SR. Nonalcoholic Fatty Liver Disease: A Review and Update. Dig Dis Sci 2010;55:560-78. [DOI: 10.1007/s10620-009-1081-0] [Cited by in Crossref: 212] [Cited by in F6Publishing: 211] [Article Influence: 17.7] [Reference Citation Analysis]
8 Cheng X, Yamauchi J, Lee S, Zhang T, Gong Z, Muzumdar R, Qu S, Dong HH. APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice. J Biol Chem. 2017;292:3692-3705. [PMID: 28115523 DOI: 10.1074/jbc.m116.765917] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Adak M, Das D, Niyogi S, Nagalakshmi C, Ray D, Chakrabarti P. Inflammasome activation in Kupffer cells confers a protective response in nonalcoholic steatohepatitis through pigment epithelium‐derived factor expression. FASEB j 2018;32:6510-24. [DOI: 10.1096/fj.201800190] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
10 Iacono A, Raso GM, Canani RB, Calignano A, Meli R. Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms. J Nutr Biochem. 2011;22:699-711. [PMID: 21292470 DOI: 10.1016/j.jnutbio.2010.10.002] [Cited by in Crossref: 113] [Cited by in F6Publishing: 117] [Article Influence: 10.3] [Reference Citation Analysis]
11 Nam H, Ferguson BS, Stephens JM, Morrison RF. Impact of obesity on IL-12 family gene expression in insulin responsive tissues. Biochim Biophys Acta 2013;1832:11-9. [PMID: 22952004 DOI: 10.1016/j.bbadis.2012.08.011] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
12 Federico A, Rosato V, Masarone M, Torre P, Dallio M, Romeo M, Persico M. The Role of Fructose in Non-Alcoholic Steatohepatitis: Old Relationship and New Insights. Nutrients 2021;13:1314. [PMID: 33923525 DOI: 10.3390/nu13041314] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Li Z, Feng PP, Zhao ZB, Zhu W, Gong JP, Du HM. Liraglutide protects against inflammatory stress in non-alcoholic fatty liver by modulating Kupffer cells M2 polarization via cAMP-PKA-STAT3 signaling pathway. Biochem Biophys Res Commun 2019;510:20-6. [PMID: 30683312 DOI: 10.1016/j.bbrc.2018.12.149] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
14 Bartuzi P, Wijshake T, Dekker DC, Fedoseienko A, Kloosterhuis NJ, Youssef SA, Li H, Shiri-Sverdlov R, Kuivenhoven JA, de Bruin A, Burstein E, Hofker MH, van de Sluis B. A cell-type-specific role for murine Commd1 in liver inflammation. Biochim Biophys Acta 2014;1842:2257-65. [PMID: 25072958 DOI: 10.1016/j.bbadis.2014.06.035] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
15 Wang SN, Lee KT, Ker CG. Leptin in hepatocellular carcinoma. World J Gastroenterol 2010; 16(46): 5801-5809 [PMID: 21155000 DOI: 10.3748/wjg.v16.i46.5801] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
16 da Silva BP, Toledo RCL, Mishima MDV, Moreira MEC, Vasconcelos CM, Pereira CER, Favarato LSC, Costa NMB, Martino HSD. Effects of chia (Salvia hispanica L.) on oxidative stress and inflammation in ovariectomized adult female Wistar rats. Food Funct 2019;10:4036-45. [PMID: 31219482 DOI: 10.1039/c9fo00862d] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
17 Iqbal U, Jadeja RN, Khara HS, Khurana S. A Comprehensive Review Evaluating the Impact of Protein Source (Vegetarian vs. Meat Based) in Hepatic Encephalopathy. Nutrients 2021;13:370. [PMID: 33530344 DOI: 10.3390/nu13020370] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Li P, He K, Li J, Liu Z, Gong J. The role of Kupffer cells in hepatic diseases. Mol Immunol. 2017;85:222-229. [PMID: 28314211 DOI: 10.1016/j.molimm.2017.02.018] [Cited by in Crossref: 89] [Cited by in F6Publishing: 87] [Article Influence: 17.8] [Reference Citation Analysis]
19 Lumeng CN, Saltiel AR. Inflammatory links between obesity and metabolic disease. J Clin Invest 2011;121:2111-7. [PMID: 21633179 DOI: 10.1172/JCI57132] [Cited by in Crossref: 1369] [Cited by in F6Publishing: 796] [Article Influence: 124.5] [Reference Citation Analysis]
20 Itagaki H, Shimizu K, Morikawa S, Ogawa K, Ezaki T. Morphological and functional characterization of non-alcoholic fatty liver disease induced by a methionine-choline-deficient diet in C57BL/6 mice. Int J Clin Exp Pathol. 2013;6:2683-2696. [PMID: 24294355 DOI: 10.1155/2013/527548] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
21 Richardson JJ, Choy MY, Guo J, Liang K, Alt K, Ping Y, Cui J, Law LS, Hagemeyer CE, Caruso F. Polymer Capsules for Plaque‐Targeted In Vivo Delivery. Adv Mater 2016;28:7703-7. [DOI: 10.1002/adma.201601754] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
22 Barrera F, George J. Non-alcoholic fatty liver disease: more than just ectopic fat accumulation. Drug Discovery Today: Disease Mechanisms 2013;10:e47-54. [DOI: 10.1016/j.ddmec.2013.06.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
23 Hatton G, Alterio T, Nobili V, Mann JP. Unmet needs in pediatric NAFLD research: what do we need to prioritize for the future? Expert Review of Gastroenterology & Hepatology 2018;12:961-7. [DOI: 10.1080/17474124.2018.1512853] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
24 Lacotte S, Slits F, Orci LA, Meyer J, Oldani G, Delaune V, Gonelle-Gispert C, Morel P, Toso C. Impact of myeloid-derived suppressor cell on Kupffer cells from mouse livers with hepatocellular carcinoma. Oncoimmunology 2016;5:e1234565. [PMID: 27999748 DOI: 10.1080/2162402X.2016.1234565] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
25 Selkälä EM, Nair RR, Schmitz W, Kvist AP, Baes M, Hiltunen JK, Autio KJ. Phytol is lethal for Amacr-deficient mice. Biochim Biophys Acta 2015;1851:1394-405. [PMID: 26248199 DOI: 10.1016/j.bbalip.2015.07.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
26 Chung MY, Park HJ, Manautou JE, Koo SI, Bruno RS. Green tea extract protects against nonalcoholic steatohepatitis in ob/ob mice by decreasing oxidative and nitrative stress responses induced by proinflammatory enzymes. J Nutr Biochem 2012;23:361-7. [PMID: 21543212 DOI: 10.1016/j.jnutbio.2011.01.001] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 4.9] [Reference Citation Analysis]
27 Hirsova P, Weng P, Salim W, Bronk SF, Griffith TS, Ibrahim SH, Gores GJ. TRAIL Deletion Prevents Liver, but Not Adipose Tissue, Inflammation during Murine Diet-Induced Obesity. Hepatol Commun 2017;1:648-62. [PMID: 29124251 DOI: 10.1002/hep4.1069] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
28 Schedlbauer C, Blaue D, Gericke M, Blüher M, Starzonek J, Gittel C, Brehm W, Vervuert I. Impact of body weight gain on hepatic metabolism and hepatic inflammatory cytokines in comparison of Shetland pony geldings and Warmblood horse geldings. PeerJ 2019;7:e7069. [PMID: 31211018 DOI: 10.7717/peerj.7069] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
29 Park JH, Ha H. Short-term Treatment of Daumone Improves Hepatic Inflammation in Aged Mice. Korean J Physiol Pharmacol 2015;19:269-74. [PMID: 25954133 DOI: 10.4196/kjpp.2015.19.3.269] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
30 Mann JP, Raponi M, Nobili V. Clinical implications of understanding the association between oxidative stress and pediatric NAFLD. Expert Rev Gastroenterol Hepatol. 2017;11:371-382. [PMID: 28162008 DOI: 10.1080/17474124.2017.1291340] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 4.6] [Reference Citation Analysis]
31 Glavind E, Gotthardt DN, Pfeiffenberger J, Sandahl TD, Bashlekova T, Willemoe GL, Hasselby JP, Weiss KH, Møller HJ, Vilstrup H, Lee WM, Schilsky ML, Ott P, Grønbæk H. The macrophage activation marker soluble CD163 is elevated and associated with liver disease phenotype in patients with Wilson's disease. Orphanet J Rare Dis 2020;15:173. [PMID: 32615997 DOI: 10.1186/s13023-020-01452-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
32 Lonardo A, Leoni S, Alswat KA, Fouad Y. History of Nonalcoholic Fatty Liver Disease. Int J Mol Sci 2020;21:E5888. [PMID: 32824337 DOI: 10.3390/ijms21165888] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
33 Wu C, Liu P, Sun MY, Bian YQ. Macrophage subsets and liver diseases. Shijie Huaren Xiaohua Zazhi 2016; 24(33): 4491-4497 [DOI: 10.11569/wcjd.v24.i33.4491] [Reference Citation Analysis]
34 Li PZ, Li JZ, Li M, Gong JP, He K. An efficient method to isolate and culture mouse Kupffer cells. Immunol Lett. 2014;158:52-56. [PMID: 24333337 DOI: 10.1016/j.imlet.2013.12.002] [Cited by in Crossref: 79] [Cited by in F6Publishing: 80] [Article Influence: 8.8] [Reference Citation Analysis]
35 Knaapen M, Kootte R, Zoetendal E, de Vos W, Dallinga-thie G, Levi M, Stroes E, Nieuwdorp M. Obesity, non-alcoholic fatty liver disease, and atherothrombosis: a role for the intestinal microbiota? Clinical Microbiology and Infection 2013;19:331-7. [DOI: 10.1111/1469-0691.12170] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
36 Li Y, Jadhav K, Zhang Y. Bile acid receptors in non-alcoholic fatty liver disease. Biochem Pharmacol. 2013;86:1517-1524. [PMID: 23988487 DOI: 10.1016/j.bcp.2013.08.015] [Cited by in Crossref: 74] [Cited by in F6Publishing: 78] [Article Influence: 8.2] [Reference Citation Analysis]
37 Cariello M, Piccinin E, Moschetta A. Transcriptional Regulation of Metabolic Pathways via Lipid-Sensing Nuclear Receptors PPARs, FXR, and LXR in NASH. Cell Mol Gastroenterol Hepatol 2021;11:1519-39. [PMID: 33545430 DOI: 10.1016/j.jcmgh.2021.01.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
38 Pompili S, Vetuschi A, Gaudio E, Tessitore A, Capelli R, Alesse E, Latella G, Sferra R, Onori P. Long-term abuse of a high-carbohydrate diet is as harmful as a high-fat diet for development and progression of liver injury in a mouse model of NAFLD/NASH. Nutrition 2020;75-76:110782. [PMID: 32268264 DOI: 10.1016/j.nut.2020.110782] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
39 Gallego-Durán R, Ampuero J, Funuyet J, Romero-Gómez M. [Alcoholic and non-alcoholic steatohepatitis: who is affected and what can we do for them?]. Gastroenterol Hepatol. 2013;36:587-596. [PMID: 24011648 DOI: 10.1016/j.gastrohep.2013.06.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
40 Zheng T, Chen B, Yang L, Hu X, Zhang X, Liu H, Qin L. Association of plasma dipeptidyl peptidase-4 activity with non-alcoholic fatty liver disease in nondiabetic Chinese population. Metabolism 2017;73:125-34. [DOI: 10.1016/j.metabol.2017.04.012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
41 Li J, Li X, Li Z, Zhang L, Liu Y, Ding H, Yin S. Isofraxidin, a coumarin component improves high-fat diet induced hepatic lipid homeostasis disorder and macrophage inflammation in mice. Food Funct 2017;8:2886-96. [DOI: 10.1039/c7fo00290d] [Cited by in Crossref: 22] [Cited by in F6Publishing: 7] [Article Influence: 4.4] [Reference Citation Analysis]
42 Bieghs V, Hendrikx T, van Gorp PJ, Verheyen F, Guichot YD, Walenbergh SM, Jeurissen ML, Gijbels M, Rensen SS, Bast A, Plat J, Kalhan SC, Koek GH, Leitersdorf E, Hofker MH, Lütjohann D, Shiri-Sverdlov R. The cholesterol derivative 27-hydroxycholesterol reduces steatohepatitis in mice. Gastroenterology 2013;144:167-178.e1. [PMID: 23041327 DOI: 10.1053/j.gastro.2012.09.062] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 5.7] [Reference Citation Analysis]
43 Davidson MD, Lehrer M, Khetani SR. Hormone and Drug-Mediated Modulation of Glucose Metabolism in a Microscale Model of the Human Liver. Tissue Eng Part C Methods 2015;21:716-25. [PMID: 25517416 DOI: 10.1089/ten.TEC.2014.0512] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
44 Adenote A, Dumic I, Madrid C, Barusya C, Nordstrom CW, Rueda Prada L. NAFLD and Infection, a Nuanced Relationship. Can J Gastroenterol Hepatol 2021;2021:5556354. [PMID: 33977096 DOI: 10.1155/2021/5556354] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Gustafson HH, Holt-Casper D, Grainger DW, Ghandehari H. Nanoparticle Uptake: The Phagocyte Problem. Nano Today 2015;10:487-510. [PMID: 26640510 DOI: 10.1016/j.nantod.2015.06.006] [Cited by in Crossref: 523] [Cited by in F6Publishing: 468] [Article Influence: 74.7] [Reference Citation Analysis]
46 Jang HH, Nam SY, Kim MJ, Kim JB, Choi JS, Kim HR, Lee YM. Agrimonia pilosa Ledeb. aqueous extract improves impaired glucose tolerance in high-fat diet-fed rats by decreasing the inflammatory response. BMC Complement Altern Med 2017;17:442. [PMID: 28870184 DOI: 10.1186/s12906-017-1949-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
47 Kermanizadeh A, Chauché C, Balharry D, Brown DM, Kanase N, Boczkowski J, Lanone S, Stone V. The role of Kupffer cells in the hepatic response to silver nanoparticles. Nanotoxicology 2014;8:149-54. [DOI: 10.3109/17435390.2013.866284] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
48 Balaban YH. A key problem and challenge for hepatology: Obesity-related metabolic liver diseases. World J Hepatol 2011; 3(6): 142-146 [PMID: 21860673 DOI: 10.4254/wjh.v3.i6.142] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
49 Fotiadu A, Gagalis A, Akriviadis E, Kotoula V, Sinakos E, Karkavelas G, Hytiroglou P. Clinicopathological correlations in a series of adult patients with non-alcoholic fatty liver disease. Pathol Int 2010;60:87-92. [PMID: 20398192 DOI: 10.1111/j.1440-1827.2009.02489.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
50 Sampey BP, Vanhoose AM, Winfield HM, Freemerman AJ, Muehlbauer MJ, Fueger PT, Newgard CB, Makowski L. Cafeteria diet is a robust model of human metabolic syndrome with liver and adipose inflammation: comparison to high-fat diet. Obesity (Silver Spring). 2011;19:1109-1117. [PMID: 21331068 DOI: 10.1038/oby.2011.18] [Cited by in Crossref: 343] [Cited by in F6Publishing: 332] [Article Influence: 31.2] [Reference Citation Analysis]
51 Tatsushima K, Hasuzawa N, Wang L, Hiasa M, Sakamoto S, Ashida K, Sudo N, Moriyama Y, Nomura M. Vesicular ATP release from hepatocytes plays a role in the progression of nonalcoholic steatohepatitis. Biochim Biophys Acta Mol Basis Dis 2021;1867:166013. [PMID: 33212187 DOI: 10.1016/j.bbadis.2020.166013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
52 Ganz M, Szabo G. Immune and inflammatory pathways in NASH. Hepatol Int. 2013;7 Suppl 2:771-781. [PMID: 24587847 DOI: 10.1007/s12072-013-9468-6] [Cited by in Crossref: 104] [Cited by in F6Publishing: 100] [Article Influence: 11.6] [Reference Citation Analysis]
53 Jestin M, Kapnick SM, Tarasenko TN, Burke CT, Zerfas PM, Diaz F, Vernon H, Singh LN, Sokol RJ, McGuire PJ. Mitochondrial disease disrupts hepatic allostasis and lowers the threshold for immune-mediated liver toxicity. Mol Metab 2020;37:100981. [PMID: 32283081 DOI: 10.1016/j.molmet.2020.100981] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Zhong S, Zhao L, Wang Y, Zhang C, Liu J, Wang P, Zhou W, Yang P, Varghese Z, Moorhead JF, Chen Y, Ruan XZ. Cluster of Differentiation 36 Deficiency Aggravates Macrophage Infiltration and Hepatic Inflammation by Upregulating Monocyte Chemotactic Protein-1 Expression of Hepatocytes Through Histone Deacetylase 2-Dependent Pathway. Antioxid Redox Signal 2017;27:201-14. [PMID: 27967209 DOI: 10.1089/ars.2016.6808] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
55 Stewart MS, Heerwagen MJ, Friedman JE. Developmental programming of pediatric nonalcoholic fatty liver disease: redefining the"first hit". Clin Obstet Gynecol 2013;56:577-90. [PMID: 23835912 DOI: 10.1097/GRF.0b013e3182a09760] [Cited by in Crossref: 29] [Cited by in F6Publishing: 11] [Article Influence: 3.6] [Reference Citation Analysis]
56 Kermanizadeh A, Løhr M, Roursgaard M, Messner S, Gunness P, Kelm JM, Møller P, Stone V, Loft S. Hepatic toxicology following single and multiple exposure of engineered nanomaterials utilising a novel primary human 3D liver microtissue model. Part Fibre Toxicol 2014;11:56. [PMID: 25326698 DOI: 10.1186/s12989-014-0056-2] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 6.9] [Reference Citation Analysis]
57 Alisi A, Carpino G, Oliveira FL, Panera N, Nobili V, Gaudio E. The Role of Tissue Macrophage-Mediated Inflammation on NAFLD Pathogenesis and Its Clinical Implications. Mediators Inflamm. 2017;2017:8162421. [PMID: 28115795 DOI: 10.1155/2017/8162421] [Cited by in Crossref: 72] [Cited by in F6Publishing: 68] [Article Influence: 14.4] [Reference Citation Analysis]
58 Yao J, Zhao Y, Zhang J, Hong Y, Lu H, Wu J. Serum amylase levels are decreased in Chinese non-alcoholic fatty liver disease patients. Lipids Health Dis 2014;13:185. [PMID: 25481429 DOI: 10.1186/1476-511X-13-185] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
59 Roth JD, Feigh M, Veidal SS, Fensholdt LK, Rigbolt KT, Hansen HH, Chen LC, Petitjean M, Friley W, Vrang N, Jelsing J, Young M. INT-767 improves histopathological features in a diet-induced ob/ob mouse model of biopsy-confirmed non-alcoholic steatohepatitis. World J Gastroenterol 2018; 24(2): 195-210 [PMID: 29375205 DOI: 10.3748/wjg.v24.i2.195] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 27] [Article Influence: 7.8] [Reference Citation Analysis]
60 Vilà L, Elias I, Roca C, Ribera A, Ferré T, Casellas A, Lage R, Franckhauser S, Bosch F. AAV8-mediated Sirt1 gene transfer to the liver prevents high carbohydrate diet-induced nonalcoholic fatty liver disease. Mol Ther Methods Clin Dev 2014;1:14039. [PMID: 26015978 DOI: 10.1038/mtm.2014.39] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
61 Li L, Fu J, Liu D, Sun J, Hou Y, Chen C, Shao J, Wang L, Wang X, Zhao R, Wang H, Andersen ME, Zhang Q, Xu Y, Pi J. Hepatocyte-specific Nrf2 deficiency mitigates high-fat diet-induced hepatic steatosis: Involvement of reduced PPARγ expression. Redox Biol 2020;30:101412. [PMID: 31901728 DOI: 10.1016/j.redox.2019.101412] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
62 Hsu YL, Chen YW, Lin CY, Lai YC, Chen SC, Lin ZY. Variable uptake feature of focal nodular hyperplasia in Tc-99m phytate hepatic scintigraphy/single-photon emission computed tomography-A parametric analysis. Kaohsiung J Med Sci 2015;31:621-5. [PMID: 26709223 DOI: 10.1016/j.kjms.2015.09.010] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
63 Kazankov K, Tordjman J, Møller HJ, Vilstrup H, Poitou C, Bedossa P, Bouillot JL, Clement K, Grønbaek H. Macrophage activation marker soluble CD163 and non-alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery. J Gastroenterol Hepatol 2015;30:1293-300. [PMID: 25772748 DOI: 10.1111/jgh.12943] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 7.2] [Reference Citation Analysis]
64 Schwenger KJ, Clermont-Dejean N, Allard JP. The role of the gut microbiome in chronic liver disease: the clinical evidence revised. JHEP Rep 2019;1:214-26. [PMID: 32039372 DOI: 10.1016/j.jhepr.2019.04.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 9.7] [Reference Citation Analysis]
65 Li X, Guo X, Ji H, Niu J, Gao P. Relationships between Metabolic Comorbidities and Occurrence, Severity, and Outcomes in Patients with Acute Pancreatitis: A Narrative Review. Biomed Res Int 2019;2019:2645926. [PMID: 31687382 DOI: 10.1155/2019/2645926] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
66 Gholamalian R, Mahdavi AH, Riasi A. Hepatic fatty acids profile, oxidative stability and egg quality traits ameliorated by supplementation of alternative lipid sources and milk thistle meal. J Anim Physiol Anim Nutr (Berl) 2021. [PMID: 34156129 DOI: 10.1111/jpn.13586] [Reference Citation Analysis]
67 Jiang X, Guo H, Shen T, Tang X, Yang Y, Ling W. Cyanidin-3- O -β-glucoside Purified from Black Rice Protects Mice against Hepatic Fibrosis Induced by Carbon Tetrachloride via Inhibiting Hepatic Stellate Cell Activation. J Agric Food Chem 2015;63:6221-30. [DOI: 10.1021/acs.jafc.5b02181] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
68 Leber B, Mayrhauser U, Rybczynski M, Stadlbauer V. Innate immune dysfunction in acute and chronic liver disease. Wien Klin Wochenschr. 2009;121:732-744. [PMID: 20047110 DOI: 10.1007/s00508-009-1288-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 32] [Article Influence: 2.2] [Reference Citation Analysis]
69 Chai NL, Zhang XB, Chen SW, Fan KX, Linghu EQ. Umbilical cord-derived mesenchymal stem cells alleviate liver fibrosis in rats. World J Gastroenterol 2016; 22(26): 6036-6048 [PMID: 27468195 DOI: 10.3748/wjg.v22.i26.6036] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
70 Li P, Zhang Z, Gong J, Zhang Y, Zhu X. S-Adenosylmethionine attenuates lipopolysaccharide-induced liver injury by downregulating the Toll-like receptor 4 signal in Kupffer cells. Hepatol Int 2014;8:275-84. [DOI: 10.1007/s12072-014-9528-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
71 Li X, Li H, Cai D, Li P, Jin J, Jiang X, Li Z, Tian L, Chen G, Sun J, Bai W. Chronic oral exposure to cadmium causes liver inflammation by NLRP3 inflammasome activation in pubertal mice. Food Chem Toxicol 2021;148:111944. [PMID: 33359024 DOI: 10.1016/j.fct.2020.111944] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
72 Fernando DH, Forbes JM, Angus PW, Herath CB. Development and Progression of Non-Alcoholic Fatty Liver Disease: The Role of Advanced Glycation End Products. Int J Mol Sci. 2019;20. [PMID: 31614491 DOI: 10.3390/ijms20205037] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
73 Kloc M, Uosef A, Kubiak JZ, Ghobrial RM. Role of Macrophages and RhoA Pathway in Atherosclerosis. Int J Mol Sci 2020;22:E216. [PMID: 33379334 DOI: 10.3390/ijms22010216] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
74 Rainer F, Horvath A, Sandahl TD, Leber B, Schmerboeck B, Blesl A, Groselj-Strele A, Stauber RE, Fickert P, Stiegler P, Møller HJ, Grønbaek H, Stadlbauer V. Soluble CD163 and soluble mannose receptor predict survival and decompensation in patients with liver cirrhosis, and correlate with gut permeability and bacterial translocation. Aliment Pharmacol Ther 2018;47:657-64. [PMID: 29266346 DOI: 10.1111/apt.14474] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 5.4] [Reference Citation Analysis]
75 Thorn SR, Baquero KC, Newsom SA, El Kasmi KC, Bergman BC, Shulman GI, Grove KL, Friedman JE. Early life exposure to maternal insulin resistance has persistent effects on hepatic NAFLD in juvenile nonhuman primates. Diabetes 2014;63:2702-13. [PMID: 24705404 DOI: 10.2337/db14-0276] [Cited by in Crossref: 63] [Cited by in F6Publishing: 56] [Article Influence: 7.9] [Reference Citation Analysis]
76 Egan CE, Daugherity EK, Rogers AB, Abi Abdallah DS, Denkers EY, Maurer KJ. CCR2 and CD44 promote inflammatory cell recruitment during fatty liver formation in a lithogenic diet fed mouse model. PLoS One 2013;8:e65247. [PMID: 23762326 DOI: 10.1371/journal.pone.0065247] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
77 Hegazy MA, Mogawer SM, Alnaggar ARLR, Ghoniem OA, Abdel Samie RM. Serum LPS and CD163 Biomarkers Confirming the Role of Gut Dysbiosis in Overweight Patients with NASH. Diabetes Metab Syndr Obes 2020;13:3861-72. [PMID: 33116732 DOI: 10.2147/DMSO.S249949] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
78 Mackei M, Molnár A, Nagy S, Pál L, Kővágó C, Gálfi P, Dublecz K, Husvéth F, Neogrády Z, Mátis G. Effects of Acute Heat Stress on a Newly Established Chicken Hepatocyte-Nonparenchymal Cell Co-Culture Model. Animals (Basel) 2020;10:E409. [PMID: 32121577 DOI: 10.3390/ani10030409] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
79 Zhang Y, Wu B, Zhang H, Ge X, Ying S, Hu M, Li W, Huang Y, Wang L, Chen C, Shan X, Liang G. Inhibition of MD2-dependent inflammation attenuates the progression of non-alcoholic fatty liver disease. J Cell Mol Med 2018;22:936-47. [PMID: 29077272 DOI: 10.1111/jcmm.13395] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
80 Lanthier N, Molendi-Coste O, Horsmans Y, van Rooijen N, Cani PD, Leclercq IA. Kupffer cell activation is a causal factor for hepatic insulin resistance. Am J Physiol Gastrointest Liver Physiol. 2010;298:G107-G116. [PMID: 19875703 DOI: 10.1152/ajpgi.00391.2009] [Cited by in Crossref: 149] [Cited by in F6Publishing: 144] [Article Influence: 11.5] [Reference Citation Analysis]
81 Gruben N, Shiri-Sverdlov R, Koonen DP, Hofker MH. Nonalcoholic fatty liver disease: A main driver of insulin resistance or a dangerous liaison? Biochim Biophys Acta 2014;1842:2329-43. [PMID: 25128743 DOI: 10.1016/j.bbadis.2014.08.004] [Cited by in Crossref: 72] [Cited by in F6Publishing: 66] [Article Influence: 9.0] [Reference Citation Analysis]
82 Grønbæk H, Rødgaard-Hansen S, Aagaard NK, Arroyo V, Moestrup SK, Garcia E, Solà E, Domenicali M, Piano S, Vilstrup H, Møller HJ; CANONIC study investigators of the EASL-CLIF Consortium. Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF). J Hepatol 2016;64:813-22. [PMID: 26639396 DOI: 10.1016/j.jhep.2015.11.021] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 9.3] [Reference Citation Analysis]
83 Wenfeng Z, Yakun W, Di M, Jianping G, Chuanxin W, Chun H. Kupffer cells: increasingly significant role in nonalcoholic fatty liver disease. Annals of Hepatology 2014;13:489-95. [DOI: 10.1016/s1665-2681(19)31247-5] [Cited by in Crossref: 58] [Article Influence: 7.3] [Reference Citation Analysis]
84 Kazankov K, Alisi A, Møller HJ, De Vito R, Rittig S, Mahler B, Nobili V, Grønbæk H. Macrophage Markers Are Poorly Associated With Liver Histology in Children With Nonalcoholic Fatty Liver Disease. J Pediatr Gastroenterol Nutr 2018;67:635-42. [PMID: 30074574 DOI: 10.1097/MPG.0000000000002111] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
85 Xu J, Chi F, Guo T, Punj V, Lee WN, French SW, Tsukamoto H. NOTCH reprograms mitochondrial metabolism for proinflammatory macrophage activation. J Clin Invest 2015;125:1579-90. [PMID: 25798621 DOI: 10.1172/JCI76468] [Cited by in Crossref: 121] [Cited by in F6Publishing: 85] [Article Influence: 17.3] [Reference Citation Analysis]
86 Maeda H, Yoshida K. Intermittent hypoxia upregulates hepatic heme oxygenase-1 and ferritin-1, thereby limiting hepatic pathogenesis in rats fed a high-fat diet. Free Radic Res 2016;50:720-31. [PMID: 27021659 DOI: 10.3109/10715762.2016.1170125] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
87 Di Naso FC, Porto RR, Fillmann HS, Maggioni L, Padoin AV, Ramos RJ, Mottin CC, Bittencourt A, Marroni NA, de Bittencourt PI. Obesity depresses the anti-inflammatory HSP70 pathway, contributing to NAFLD progression. Obesity (Silver Spring). 2015;23:120-129. [PMID: 25292174 DOI: 10.1002/oby.20919] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 6.9] [Reference Citation Analysis]
88 Alisi A, Manco M, Devito R, Nobili V. Fatty Liver Disease. In: Freemark M, editor. Pediatric Obesity. New York: Springer; 2010. pp. 201-22. [DOI: 10.1007/978-1-60327-874-4_15] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
89 Wang H, Li L, Li Y, Li Y, Sha Y, Wen S, You Q, Liu L, Shi M, Zhou H. Intravital imaging of interactions between iNKT and kupffer cells to clear free lipids during steatohepatitis. Theranostics 2021;11:2149-69. [PMID: 33500717 DOI: 10.7150/thno.51369] [Reference Citation Analysis]
90 Inzaugarat ME, De Matteo E, Baz P, Lucero D, García CC, Gonzalez Ballerga E, Daruich J, Sorda JA, Wald MR, Cherñavsky AC. New evidence for the therapeutic potential of curcumin to treat nonalcoholic fatty liver disease in humans. PLoS One 2017;12:e0172900. [PMID: 28257515 DOI: 10.1371/journal.pone.0172900] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
91 Heinbokel T, Floerchinger B, Schmiderer A, Edtinger K, Liu G, Elkhal A, Tullius SG. Obesity and Its Impact on Transplantation and Alloimmunity. Transplantation 2013;96:10-6. [DOI: 10.1097/tp.0b013e3182869d2f] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
92 Kazankov K, Møller HJ, Lange A, Birkebaek NH, Holland-Fischer P, Solvig J, Hørlyck A, Kristensen K, Rittig S, Handberg A, Vilstrup H, Grønbaek H. The macrophage activation marker sCD163 is associated with changes in NAFLD and metabolic profile during lifestyle intervention in obese children. Pediatr Obes 2015;10:226-33. [PMID: 25073966 DOI: 10.1111/ijpo.252] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 5.0] [Reference Citation Analysis]
93 Pierce AA, Duwaerts CC, Siao K, Mattis AN, Goodsell A, Baron JL, Maher JJ. CD18 deficiency improves liver injury in the MCD model of steatohepatitis. PLoS One 2017;12:e0183912. [PMID: 28873429 DOI: 10.1371/journal.pone.0183912] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
94 Koyama N, Yamazaki T, Kanetsuki Y, Hirota J, Asai T, Mitsumoto Y, Mizuno M, Shima T, Kanbara Y, Arai S. Activation of apoptosis inhibitor of macrophage is a sensitive diagnostic marker for NASH-associated hepatocellular carcinoma. J Gastroenterol. 2018;53:770-779. [PMID: 29086016 DOI: 10.1007/s00535-017-1398-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
95 Pimentel GD, Micheletti TO, Pace F. Nutritional Targets for Modulation of the Microbiota in Obesity: Nutritional Targets for Obesity. Drug Dev Res 2013;74:393-402. [DOI: 10.1002/ddr.21092] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
96 Campion D, Giovo I, Ponzo P, Saracco GM, Balzola F, Alessandria C. Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis. World J Hepatol 2019; 11(6): 489-512 [PMID: 31293718 DOI: 10.4254/wjh.v11.i6.489] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
97 Lv F, Wu J, Miao D, An W, Wang Y. p16 deficiency promotes nonalcoholic steatohepatitis via regulation of hepatic oxidative stress. Biochemical and Biophysical Research Communications 2017;486:264-9. [DOI: 10.1016/j.bbrc.2017.03.023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
98 Cruz AF, Rohban R, Esni F. Macrophages in the pancreas: Villains by circumstances, not necessarily by actions. Immun Inflamm Dis 2020;8:807-24. [PMID: 32885589 DOI: 10.1002/iid3.345] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
99 Beattie L, Sawtell A, Mann J, Frame TCM, Teal B, de Labastida Rivera F, Brown N, Walwyn-Brown K, Moore JWJ, MacDonald S, Lim EK, Dalton JE, Engwerda CR, MacDonald KP, Kaye PM. Bone marrow-derived and resident liver macrophages display unique transcriptomic signatures but similar biological functions. J Hepatol 2016;65:758-68. [PMID: 27262757 DOI: 10.1016/j.jhep.2016.05.037] [Cited by in Crossref: 105] [Cited by in F6Publishing: 97] [Article Influence: 17.5] [Reference Citation Analysis]
100 Lumeng CN. Innate immune activation in obesity. Mol Aspects Med. 2013;34:12-29. [PMID: 23068074 DOI: 10.1016/j.mam.2012.10.002] [Cited by in Crossref: 87] [Cited by in F6Publishing: 92] [Article Influence: 8.7] [Reference Citation Analysis]
101 Wu R, Nakatsu G, Zhang X, Yu J. Pathophysiological mechanisms and therapeutic potentials of macrophages in non-alcoholic steatohepatitis. Expert Opin Ther Targets. 2016;20:615-626. [PMID: 26609894 DOI: 10.1517/14728222.2016.1125883] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
102 Ruiz-Ojeda FJ, Méndez-Gutiérrez A, Aguilera CM, Plaza-Díaz J. Extracellular Matrix Remodeling of Adipose Tissue in Obesity and Metabolic Diseases. Int J Mol Sci 2019;20:E4888. [PMID: 31581657 DOI: 10.3390/ijms20194888] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 14.0] [Reference Citation Analysis]
103 Tse E, Helbig KJ, Van der Hoek K, McCartney EM, Van der Hoek M, George J, Beard MR. Fatty Acids Induce a Pro-Inflammatory Gene Expression Profile in Huh-7 Cells That Attenuates the Anti-HCV Action of Interferon. J Interferon Cytokine Res 2015;35:392-400. [PMID: 25588104 DOI: 10.1089/jir.2014.0165] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
104 Ko JS. Nonalcoholic Fatty Liver Disease. Korean J Gastroenterol 2010;56:6. [DOI: 10.4166/kjg.2010.56.1.6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
105 Peng C, Stewart AG, Woodman OL, Ritchie RH, Qin CX. Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments. Front Pharmacol 2020;11:603926. [PMID: 33343375 DOI: 10.3389/fphar.2020.603926] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
106 Jonscher KR, Abrams J, Friedman JE. Maternal Diet Alters Trained Immunity in the Pathogenesis of Pediatric NAFLD. J Cell Immunol 2020;2:315-25. [PMID: 33426540 DOI: 10.33696/immunology.2.061] [Reference Citation Analysis]
107 Cudejko C, Wouters K, Fuentes L, Hannou SA, Paquet C, Bantubungi K, Bouchaert E, Vanhoutte J, Fleury S, Remy P, Tailleux A, Chinetti-Gbaguidi G, Dombrowicz D, Staels B, Paumelle R. p16INK4a deficiency promotes IL-4-induced polarization and inhibits proinflammatory signaling in macrophages. Blood 2011;118:2556-66. [PMID: 21636855 DOI: 10.1182/blood-2010-10-313106] [Cited by in Crossref: 63] [Cited by in F6Publishing: 61] [Article Influence: 5.7] [Reference Citation Analysis]
108 Lam P, Cheung F, Tan HY, Wang N, Yuen MF, Feng Y. Hepatoprotective Effects of Chinese Medicinal Herbs: A Focus on Anti-Inflammatory and Anti-Oxidative Activities. Int J Mol Sci. 2016;17:465. [PMID: 27043533 DOI: 10.3390/ijms17040465] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 9.3] [Reference Citation Analysis]
109 Mouralidarane A, Soeda J, Visconti-pugmire C, Samuelsson A, Pombo J, Maragkoudaki X, Butt A, Saraswati R, Novelli M, Fusai G, Poston L, Taylor PD, Oben JA. Maternal obesity programs offspring nonalcoholic fatty liver disease by innate immune dysfunction in mice. Hepatology 2013;58:128-38. [DOI: 10.1002/hep.26248] [Cited by in Crossref: 88] [Cited by in F6Publishing: 75] [Article Influence: 9.8] [Reference Citation Analysis]
110 Diehl KL, Vorac J, Hofmann K, Meiser P, Unterweger I, Kuerschner L, Weighardt H, Förster I, Thiele C. Kupffer Cells Sense Free Fatty Acids and Regulate Hepatic Lipid Metabolism in High-Fat Diet and Inflammation. Cells 2020;9:E2258. [PMID: 33050035 DOI: 10.3390/cells9102258] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
111 Yang W, Liu L, Wei Y, Fang C, Liu S, Zhou F, Li Y, Zhao G, Guo Z, Luo Y, Li L. Exercise suppresses NLRP3 inflammasome activation in mice with diet-induced NASH: a plausible role of adropin. Lab Invest 2021;101:369-80. [PMID: 33268842 DOI: 10.1038/s41374-020-00508-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
112 Volynets V, Machann J, Küper MA, Maier IB, Spruss A, Königsrainer A, Bischoff SC, Bergheim I. A moderate weight reduction through dietary intervention decreases hepatic fat content in patients with non-alcoholic fatty liver disease (NAFLD): a pilot study. Eur J Nutr. 2013;52:527-535. [PMID: 22543623 DOI: 10.1007/s00394-012-0355-z] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 4.9] [Reference Citation Analysis]
113 Liu J, Yuan Y, Gong X, Zhang L, Zhou Q, Wu S, Zhang X, Hu J, Kuang G, Yin X, Wan J, Yuan Y. Baicalin and its nanoliposomes ameliorates nonalcoholic fatty liver disease via suppression of TLR4 signaling cascade in mice. Int Immunopharmacol 2020;80:106208. [PMID: 31955065 DOI: 10.1016/j.intimp.2020.106208] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
114 ALTamimi JZ, Alshammari GM, AlFaris NA, Alagal RI, Aljabryn DH, Albekairi NA, Alkhateeb MA, Yahya MA. Ellagic acid protects against non-alcoholic fatty liver disease in streptozotocin-diabetic rats by activating AMPK. Pharm Biol 2022;60:25-37. [PMID: 34870551 DOI: 10.1080/13880209.2021.1990969] [Reference Citation Analysis]
115 Oates JR, McKell MC, Moreno-Fernandez ME, Damen MSMA, Deepe GS Jr, Qualls JE, Divanovic S. Macrophage Function in the Pathogenesis of Non-alcoholic Fatty Liver Disease: The Mac Attack. Front Immunol 2019;10:2893. [PMID: 31921154 DOI: 10.3389/fimmu.2019.02893] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
116 Debnath M, Agrawal S, Agrawal A, Dubey GP. Metaflammatory responses during obesity: Pathomechanism and treatment. Obes Res Clin Pract. 2016;10:103-113. [PMID: 26614484 DOI: 10.1016/j.orcp.2015.10.012] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
117 Than NN, Newsome PN. A concise review of non-alcoholic fatty liver disease. Atherosclerosis. 2015;239:192-202. [PMID: 25617860 DOI: 10.1016/j.atherosclerosis.2015.01.001] [Cited by in Crossref: 175] [Cited by in F6Publishing: 164] [Article Influence: 25.0] [Reference Citation Analysis]
118 Debes JD, Bohjanen PR, Boonstra A. Mechanisms of Accelerated Liver Fibrosis Progression during HIV Infection. J Clin Transl Hepatol. 2016;4:328-335. [PMID: 28097102 DOI: 10.14218/jcth.2016.00034] [Cited by in Crossref: 3] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
119 Friedman SL. Focus. Metchnikoff, macrophages and the metabolic syndrome. J Hepatol 2012;57:1-2. [PMID: 22522383 DOI: 10.1016/j.jhep.2012.04.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
120 Lin R, Zhang J, Zhou L, Wang B. Altered function of monocytes/macrophages in patients with autoimmune hepatitis. Mol Med Rep 2016;13:3874-80. [PMID: 26986756 DOI: 10.3892/mmr.2016.4998] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
121 Liu G, Cui Z, Gao X, Liu H, Wang L, Gong J, Wang A, Zhang J, Ma Q, Huang Y, Piao G, Yuan H. Corosolic acid ameliorates non-alcoholic steatohepatitis induced by high-fat diet and carbon tetrachloride by regulating TGF-β1/Smad2, NF-κB, and AMPK signaling pathways. Phytother Res 2021. [PMID: 34213784 DOI: 10.1002/ptr.7195] [Reference Citation Analysis]
122 Zhang C, Zhang J, Liu Z, Zhou Z. More than an Anti-diabetic Bariatric Surgery, Metabolic Surgery Alleviates Systemic and Local Inflammation in Obesity. Obes Surg 2018;28:3658-68. [PMID: 30187424 DOI: 10.1007/s11695-018-3400-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
123 Chatterjee S, Rana R, Corbett J, Kadiiska MB, Goldstein J, Mason RP. P2X7 receptor-NADPH oxidase axis mediates protein radical formation and Kupffer cell activation in carbon tetrachloride-mediated steatohepatitis in obese mice. Free Radic Biol Med 2012;52:1666-79. [PMID: 22343416 DOI: 10.1016/j.freeradbiomed.2012.02.010] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 4.0] [Reference Citation Analysis]
124 Calabuig-Navarro V, Yamauchi J, Lee S, Zhang T, Liu YZ, Sadlek K, Coudriet GM, Piganelli JD, Jiang CL, Miller R, Lowe M, Harashima H, Dong HH. Forkhead Box O6 (FoxO6) Depletion Attenuates Hepatic Gluconeogenesis and Protects against Fat-induced Glucose Disorder in Mice. J Biol Chem 2015;290:15581-94. [PMID: 25944898 DOI: 10.1074/jbc.M115.650994] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
125 Keitel V, Häussinger D. Perspective: TGR5 (Gpbar-1) in liver physiology and disease. Clin Res Hepatol Gastroenterol 2012;36:412-9. [PMID: 22521118 DOI: 10.1016/j.clinre.2012.03.008] [Cited by in Crossref: 76] [Cited by in F6Publishing: 76] [Article Influence: 7.6] [Reference Citation Analysis]
126 Zhan YT, An W. Roles of liver innate immune cells in nonalcoholic fatty liver disease. World J Gastroenterol 2010; 16(37): 4652-4660 [PMID: 20872965 DOI: 10.3748/wjg.v16.i37.4652] [Cited by in CrossRef: 59] [Cited by in F6Publishing: 62] [Article Influence: 4.9] [Reference Citation Analysis]
127 Pols TW, Noriega LG, Nomura M, Auwerx J, Schoonjans K. The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation. J Hepatol 2011;54:1263-72. [PMID: 21145931 DOI: 10.1016/j.jhep.2010.12.004] [Cited by in Crossref: 227] [Cited by in F6Publishing: 222] [Article Influence: 18.9] [Reference Citation Analysis]
128 Yao J, Zhou CS, Ma X, Fu BQ, Tao LS, Chen M, Xu YP. FXR agonist GW4064 alleviates endotoxin-induced hepatic inflammation by repressing macrophage activation. World J Gastroenterol 2014; 20(39): 14430-14441 [PMID: 25339829 DOI: 10.3748/wjg.v20.i39.14430] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 33] [Article Influence: 4.3] [Reference Citation Analysis]
129 Khadge S, Sharp JG, McGuire TR, Thiele GM, Black P, DiRusso C, Cook L, Klassen LW, Talmadge JE. Immune regulation and anti-cancer activity by lipid inflammatory mediators. Int Immunopharmacol 2018;65:580-92. [PMID: 30447537 DOI: 10.1016/j.intimp.2018.10.026] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
130 Navarro LA, Wree A, Povero D, Berk MP, Eguchi A, Ghosh S, Papouchado BG, Erzurum SC, Feldstein AE. Arginase 2 deficiency results in spontaneous steatohepatitis: a novel link between innate immune activation and hepatic de novo lipogenesis. J Hepatol. 2015;62:412-420. [PMID: 25234945 DOI: 10.1016/j.jhep.2014.09.015] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 5.3] [Reference Citation Analysis]
131 Ryou M, Stylopoulos N, Baffy G. Nonalcoholic fatty liver disease and portal hypertension. Explor Med 2020;1:149-69. [PMID: 32685936 DOI: 10.37349/emed.2020.00011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
132 Wan L, Jiang J. Protective effects of plant-derived flavonoids on hepatic injury. Journal of Functional Foods 2018;44:283-91. [DOI: 10.1016/j.jff.2018.03.015] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
133 Chait A, den Hartigh LJ. Adipose tissue distribution, inflammation and its metabolic consequences, including diabetes and cardiovascular disease. Front Cardiovasc Med. 2020;7:22. [PMID: 32158768 DOI: 10.3389/fcvm.2020.00022] [Cited by in Crossref: 107] [Cited by in F6Publishing: 114] [Article Influence: 53.5] [Reference Citation Analysis]
134 Jegatheesan P, De Bandt JP. Fructose and NAFLD: The Multifaceted Aspects of  Fructose Metabolism. Nutrients 2017;9:E230. [PMID: 28273805 DOI: 10.3390/nu9030230] [Cited by in Crossref: 82] [Cited by in F6Publishing: 23] [Article Influence: 16.4] [Reference Citation Analysis]
135 Fan Y, Song X, Gao Y, Chen Y, Ma L, Zhang W, Hou W, Guo C, Tong D. Preparation and optimization of ophiopogon polysaccharide liposome and its activity on Kupffer cells. International Journal of Pharmaceutics 2014;477:421-30. [DOI: 10.1016/j.ijpharm.2014.10.053] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
136 Vos MB. Furthering the understanding of maternal obesity in nonalcoholic fatty liver disease. Hepatology 2013;58:4-5. [PMID: 23504746 DOI: 10.1002/hep.26389] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
137 Møller S, Henriksen JH, Bendtsen F. Extrahepatic complications to cirrhosis and portal hypertension: Haemodynamic and homeostatic aspects. World J Gastroenterol 2014; 20(42): 15499-15517 [PMID: 25400435 DOI: 10.3748/wjg.v20.i42.15499] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 32] [Article Influence: 4.9] [Reference Citation Analysis]
138 Lanthier N, Molendi-Coste O, Cani PD, van Rooijen N, Horsmans Y, Leclercq IA. Kupffer cell depletion prevents but has no therapeutic effect on metabolic and inflammatory changes induced by a high-fat diet. FASEB J. 2011;25:4301-4311. [PMID: 21873555 DOI: 10.1096/fj.11-189472] [Cited by in Crossref: 75] [Cited by in F6Publishing: 77] [Article Influence: 6.8] [Reference Citation Analysis]
139 Baffy G. Origins of Portal Hypertension in Nonalcoholic Fatty Liver Disease. Dig Dis Sci 2018;63:563-76. [DOI: 10.1007/s10620-017-4903-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
140 Kermanizadeh A, Gaiser BK, Johnston H, Brown DM, Stone V. Toxicological effect of engineered nanomaterials on the liver. Br J Pharmacol 2014;171:3980-7. [PMID: 24111818 DOI: 10.1111/bph.12421] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
141 Perino A, Schoonjans K. TGR5 and Immunometabolism: Insights from Physiology and Pharmacology. Trends Pharmacol Sci. 2015;36:847-857. [PMID: 26541439 DOI: 10.1016/j.tips.2015.08.002] [Cited by in Crossref: 72] [Cited by in F6Publishing: 69] [Article Influence: 10.3] [Reference Citation Analysis]
142 Frisdal E, Lesnik P, Olivier M, Robillard P, Chapman MJ, Huby T, Guerin M, Le Goff W. Interleukin-6 protects human macrophages from cellular cholesterol accumulation and attenuates the proinflammatory response. J Biol Chem. 2011;286:30926-30936. [PMID: 21757719 DOI: 10.1074/jbc.m111.264325] [Cited by in Crossref: 63] [Cited by in F6Publishing: 44] [Article Influence: 5.7] [Reference Citation Analysis]
143 Han J, Zhang X. Complement Component C3: A Novel Biomarker Participating in the Pathogenesis of Non-alcoholic Fatty Liver Disease. Front Med (Lausanne) 2021;8:653293. [PMID: 34395461 DOI: 10.3389/fmed.2021.653293] [Reference Citation Analysis]
144 Reiniers MJ, van Golen RF, van Gulik TM, Heger M. Reactive oxygen and nitrogen species in steatotic hepatocytes: a molecular perspective on the pathophysiology of ischemia-reperfusion injury in the fatty liver. Antioxid Redox Signal. 2014;21:1119-1142. [PMID: 24294945 DOI: 10.1089/ars.2013.5486] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 7.4] [Reference Citation Analysis]
145 Kiefer FW, Neschen S, Pfau B, Legerer B, Neuhofer A, Kahle M, Hrabé de Angelis M, Schlederer M, Mair M, Kenner L, Plutzky J, Zeyda M, Stulnig TM. Osteopontin deficiency protects against obesity-induced hepatic steatosis and attenuates glucose production in mice. Diabetologia 2011;54:2132-42. [PMID: 21562757 DOI: 10.1007/s00125-011-2170-0] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 5.4] [Reference Citation Analysis]
146 Ciavarella A, Gnocchi D, Custodero C, Lenato GM, Fiore G, Sabbà C, Mazzocca A. Translational insight into prothrombotic state and hypercoagulation in nonalcoholic fatty liver disease. Thromb Res 2021;198:139-50. [PMID: 33340925 DOI: 10.1016/j.thromres.2020.12.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
147 Eguchi K, Manabe I, Oishi-tanaka Y, Ohsugi M, Kono N, Ogata F, Yagi N, Ohto U, Kimoto M, Miyake K, Tobe K, Arai H, Kadowaki T, Nagai R. Saturated Fatty Acid and TLR Signaling Link β Cell Dysfunction and Islet Inflammation. Cell Metabolism 2012;15:518-33. [DOI: 10.1016/j.cmet.2012.01.023] [Cited by in Crossref: 316] [Cited by in F6Publishing: 296] [Article Influence: 31.6] [Reference Citation Analysis]
148 Alisi A, Panera N, Agostoni C, Nobili V. Intrauterine growth retardation and nonalcoholic Fatty liver disease in children. Int J Endocrinol 2011;2011:269853. [PMID: 22190925 DOI: 10.1155/2011/269853] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 4.5] [Reference Citation Analysis]
149 Hirsova P, Ibrahim SH, Bronk SF, Yagita H, Gores GJ. Vismodegib suppresses TRAIL-mediated liver injury in a mouse model of nonalcoholic steatohepatitis. PLoS One. 2013;8:e70599. [PMID: 23894677 DOI: 10.1371/journal.pone.0070599] [Cited by in Crossref: 65] [Cited by in F6Publishing: 60] [Article Influence: 7.2] [Reference Citation Analysis]
150 Wang XL, Jia DW, Liu HY, Yan XF, Ye TJ, Hu XD, Li BQ, Chen YL, Liu P. Effect of Yiguanjian decoction on cell differentiation and proliferation in CCl4-treated mice. World J Gastroenterol 2012; 18(25): 3235-3249 [PMID: 22783047 DOI: 10.3748/wjg.v18.i25.3235] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
151 Lonardo A, Caldwell SH, Loria P. Clinical physiology of NAFLD: a critical overview of pathogenesis and treatment. Expert Review of Endocrinology & Metabolism 2014;5:403-23. [DOI: 10.1586/eem.10.5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
152 McMahan RH, Wang XX, Cheng LL, Krisko T, Smith M, El Kasmi K, Pruzanski M, Adorini L, Golden-Mason L, Levi M, Rosen HR. Bile acid receptor activation modulates hepatic monocyte activity and improves nonalcoholic fatty liver disease. J Biol Chem. 2013;288:11761-11770. [PMID: 23460643 DOI: 10.1074/jbc.m112.446575] [Cited by in Crossref: 137] [Cited by in F6Publishing: 74] [Article Influence: 15.2] [Reference Citation Analysis]
153 Wijarnpreecha K, Panjawatanan P, Ungprasert P. Use of cannabis and risk of advanced liver fibrosis in patients with chronic hepatitis C virus infection: A systematic review and meta-analysis. J Evid Based Med 2018;11:272-7. [DOI: 10.1111/jebm.12317] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
154 Pols TW, Noriega LG, Nomura M, Auwerx J, Schoonjans K. The bile acid membrane receptor TGR5: a valuable metabolic target. Dig Dis. 2011;29:37-44. [PMID: 21691102 DOI: 10.1159/000324126] [Cited by in Crossref: 74] [Cited by in F6Publishing: 72] [Article Influence: 6.7] [Reference Citation Analysis]
155 Zehra M, Curry JC, Pillai SS, Lakhani HV, Edwards CE, Sodhi K. Elucidating Potential Profibrotic Mechanisms of Emerging Biomarkers for Early Prognosis of Hepatic Fibrosis. Int J Mol Sci 2020;21:E4737. [PMID: 32635162 DOI: 10.3390/ijms21134737] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
156 Zampino R, Marrone A, Rinaldi L, Guerrera B, Nevola R, Boemio A, Iuliano N, Giordano M, Passariello N, Sasso FC. Endotoxinemia contributes to steatosis, insulin resistance and atherosclerosis in chronic hepatitis C: the role of pro-inflammatory cytokines and oxidative stress. Infection. 2018;. [PMID: 30066228 DOI: 10.1007/s15010-018-1185-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
157 Anavi S, Madar Z, Tirosh O. Non-alcoholic fatty liver disease, to struggle with the strangle: Oxygen availability in fatty livers. Redox Biol. 2017;13:386-392. [PMID: 28667907 DOI: 10.1016/j.redox.2017.06.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
158 Liu Y, Han X, Bian Z, Peng Y, You Z, Wang Q, Chen X, Qiu D, Ma X. Activation of liver X receptors attenuates endotoxin-induced liver injury in mice with nonalcoholic fatty liver disease. Dig Dis Sci. 2012;57:390-398. [PMID: 21948338 DOI: 10.1007/s10620-011-1902-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
159 Usta OB, McCarty WJ, Bale S, Hegde M, Jindal R, Bhushan A, Golberg I, Yarmush ML. Microengineered cell and tissue systems for drug screening and toxicology applications: Evolution of in-vitro liver technologies. Technology (Singap World Sci) 2015;3:1-26. [PMID: 26167518 DOI: 10.1142/S2339547815300012] [Cited by in Crossref: 37] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
160 Ibrahim KG, Chivandi E, Nkomozepi P, Matumba MG, Mukwevho E, Erlwanger KH. The long-term protective effects of neonatal administration of curcumin against nonalcoholic steatohepatitis in high-fructose-fed adolescent rats. Physiol Rep 2019;7:e14032. [PMID: 30912307 DOI: 10.14814/phy2.14032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
161 Garcovich M, Zocco MA, Roccarina D, Ponziani FR, Gasbarrini A. Prevention and treatment of hepatic encephalopathy: Focusing on gut microbiota. World J Gastroenterol 2012; 18(46): 6693-6700 [PMID: 23239905 DOI: 10.3748/wjg.v18.i46.6693] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 37] [Article Influence: 3.8] [Reference Citation Analysis]
162 Magee N, Zou A, Zhang Y. Pathogenesis of Nonalcoholic Steatohepatitis: Interactions between Liver Parenchymal and Nonparenchymal Cells. Biomed Res Int. 2016;2016:5170402. [PMID: 27822476 DOI: 10.1155/2016/5170402] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 9.0] [Reference Citation Analysis]
163 Tarasenko TN, Singh LN, Chatterji-Len M, Zerfas PM, Cusmano-Ozog K, McGuire PJ. Kupffer cells modulate hepatic fatty acid oxidation during infection with PR8 influenza. Biochim Biophys Acta 2015;1852:2391-401. [PMID: 26319418 DOI: 10.1016/j.bbadis.2015.08.021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
164 Kopec AK, Joshi N, Towery KL, Kassel KM, Sullivan BP, Flick MJ, Luyendyk JP. Thrombin inhibition with dabigatran protects against high-fat diet-induced fatty liver disease in mice. J Pharmacol Exp Ther. 2014;351:288-297. [PMID: 25138021 DOI: 10.1124/jpet.114.218545] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
165 Ibrahim SH, Gores GJ, Hirsova P, Kirby M, Miles L, Jaeschke A, Kohli R. Mixed lineage kinase 3 deficient mice are protected against the high fat high carbohydrate diet-induced steatohepatitis. Liver Int. 2014;34:427-437. [PMID: 24256559 DOI: 10.1111/liv.12353] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 3.7] [Reference Citation Analysis]
166 Petrasek J, Csak T, Szabo G. Toll-like receptors in liver disease. Adv Clin Chem. 2013;59:155-201. [PMID: 23461136 DOI: 10.1016/b978-0-12-405211-6.00006-1] [Cited by in Crossref: 53] [Cited by in F6Publishing: 32] [Article Influence: 5.9] [Reference Citation Analysis]
167 Yang YY, Liu RS, Lee PC, Yeh YC, Huang YT, Lee WP, Lee KC, Hsieh YC, Lee FY, Tan TW. Anti-VEGFR agents ameliorate hepatic venous dysregulation/microcirculatory dysfunction, splanchnic venous pooling and ascites of NASH-cirrhotic rat. Liver Int. 2014;34:521-534. [PMID: 23998651 DOI: 10.1111/liv.12299] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
168 Morimoto K, Watanabe M, Sugizaki T, Irie J, Itoh H. Intestinal Bile Acid Composition Modulates Prohormone Convertase 1/3 (PC1/3) Expression and Consequent GLP-1 Production in Male Mice. Endocrinology 2016;157:1071-81. [PMID: 26789236 DOI: 10.1210/en.2015-1551] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
169 Tian Y, Ma J, Wang W, Zhang L, Xu J, Wang K, Li D. Resveratrol supplement inhibited the NF-κB inflammation pathway through activating AMPKα-SIRT1 pathway in mice with fatty liver. Mol Cell Biochem 2016;422:75-84. [DOI: 10.1007/s11010-016-2807-x] [Cited by in Crossref: 79] [Cited by in F6Publishing: 73] [Article Influence: 13.2] [Reference Citation Analysis]
170 Chen J, Deng X, Liu Y, Tan Q, Huang G, Che Q, Guo J, Su Z. Kupffer Cells in Non-alcoholic Fatty Liver Disease: Friend or Foe? Int J Biol Sci 2020;16:2367-78. [PMID: 32760204 DOI: 10.7150/ijbs.47143] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
171 Boschetti E, D'Alessandro R, Bianco F, Carelli V, Cenacchi G, Pinna AD, Del Gaudio M, Rinaldi R, Stanghellini V, Pironi L, Rhoden K, Tugnoli V, Casali C, De Giorgio R. Liver as a source for thymidine phosphorylase replacement in mitochondrial neurogastrointestinal encephalomyopathy. PLoS One 2014;9:e96692. [PMID: 24802030 DOI: 10.1371/journal.pone.0096692] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
172 Mátis G, Kulcsár A, Petrilla J, Talapka P, Neogrády Z. Porcine hepatocyte-Kupffer cell co-culture as an in vitro model for testing the efficacy of anti-inflammatory substances. J Anim Physiol Anim Nutr (Berl) 2017;101:201-7. [PMID: 27450109 DOI: 10.1111/jpn.12547] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
173 Liu H, Liao R, He K, Zhu X, Li P, Gong J. The SMAC mimetic birinapant attenuates lipopolysaccharide-induced liver injury by inhibiting the tumor necrosis factor receptor–associated factor 3 degradation in Kupffer cells. Immunology Letters 2017;185:79-83. [DOI: 10.1016/j.imlet.2017.02.016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
174 Silva AKS, Peixoto CA. Role of peroxisome proliferator-activated receptors in non-alcoholic fatty liver disease inflammation. Cell Mol Life Sci. 2018;75:2951-2961. [PMID: 29789866 DOI: 10.1007/s00018-018-2838-4] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 7.8] [Reference Citation Analysis]
175 Hillian AD, McMullen MR, Sebastian BM, Roychowdhury S, Kashyap SR, Schauer PR, Kirwan JP, Feldstein AE, Nagy LE. Mice lacking C1q are protected from high fat diet-induced hepatic insulin resistance and impaired glucose homeostasis. J Biol Chem 2013;288:22565-75. [PMID: 23788643 DOI: 10.1074/jbc.M113.465674] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
176 Savic D, Hodson L, Neubauer S, Pavlides M. The Importance of the Fatty Acid Transporter L-Carnitine in Non-Alcoholic Fatty Liver Disease (NAFLD). Nutrients 2020;12:E2178. [PMID: 32708036 DOI: 10.3390/nu12082178] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
177 Fuji S, Takano K, Mori T, Eto T, Taniguchi S, Ohashi K, Sakamaki H, Morishima Y, Kato K, Miyamura K, Suzuki R, Fukuda T. Impact of pretransplant body mass index on the clinical outcome after allogeneic hematopoietic SCT. Bone Marrow Transplant 2014;49:1505-12. [PMID: 25111511 DOI: 10.1038/bmt.2014.178] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 5.4] [Reference Citation Analysis]
178 Doganay L, Katrinli S, Colak Y, Senates E, Zemheri E, Ozturk O, Enc FY, Tuncer I, Doganay GD. HLA DQB1 alleles are related with nonalcoholic fatty liver disease. Mol Biol Rep. 2014;41:7937-7943. [PMID: 25156535 DOI: 10.1007/s11033-014-3688-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
179 Kazankov K, Barrera F, Møller HJ, Rosso C, Bugianesi E, David E, Younes R, Esmaili S, Eslam M, McLeod D, Bibby BM, Vilstrup H, George J, Grønbaek H. The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver disease. Liver Int 2016;36:1549-57. [PMID: 27102725 DOI: 10.1111/liv.13150] [Cited by in Crossref: 61] [Cited by in F6Publishing: 54] [Article Influence: 10.2] [Reference Citation Analysis]
180 Liu J, Xu C, Ying L, Zang S, Zhuang Z, Lv H, Yang W, Luo Y, Ma X, Wang L. Relationship of serum uric acid level with non-alcoholic fatty liver disease and its inflammation progression in non-obese adults. Hepatol Res. 2017;47:E104-E112. [PMID: 27172177 DOI: 10.1111/hepr.12734] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
181 Kersten S. Regulation of nutrient metabolism and inflammation. Results Probl Cell Differ. 2010;52:13-25. [PMID: 20865368 DOI: 10.1007/978-3-642-14426-4_2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
182 Kanuri G, Landmann M, Priebs J, Spruss A, Löscher M, Ziegenhardt D, Röhl C, Degen C, Bergheim I. Moderate alcohol consumption diminishes the development of non-alcoholic fatty liver disease (NAFLD) in ob/ob mice. Eur J Nutr 2016;55:1153-64. [PMID: 26003186 DOI: 10.1007/s00394-015-0929-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
183 Ono M, Saibara T. Is impaired Kupffer cell function really important to the pathogenesis of nonalcoholic steatohepatitis? J Gastroenterol Hepatol 2012;27:622-4. [PMID: 22436056 DOI: 10.1111/j.1440-1746.2012.07084.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
184 Nowatzky J, Knorr A, Hirth-Dietrich C, Siegling A, Volk HD, Limmer A, Knolle P, Weber O. Inactivated Orf virus (Parapoxvirus ovis) elicits antifibrotic activity in models of liver fibrosis. Hepatol Res 2013;43:535-46. [PMID: 22971208 DOI: 10.1111/j.1872-034X.2012.01086.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
185 Jensen BAH, Holm JB, Larsen IS, von Burg N, Derer S, Sonne SB, Pærregaard SI, Damgaard MV, Indrelid SA, Rivollier A, Agrinier AL, Sulek K, Arnoldussen YJ, Fjære E, Marette A, Angell IL, Rudi K, Treebak JT, Madsen L, Åkesson CP, Agace W, Sina C, Kleiveland CR, Kristiansen K, Lea TE. Lysates of Methylococcus capsulatus Bath induce a lean-like microbiota, intestinal FoxP3+RORγt+IL-17+ Tregs and improve metabolism. Nat Commun 2021;12:1093. [PMID: 33597537 DOI: 10.1038/s41467-021-21408-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
186 Luo W, Xu Q, Wang Q, Wu H, Hua J. Effect of modulation of PPAR-γ activity on Kupffer cells M1/M2 polarization in the development of non-alcoholic fatty liver disease. Sci Rep 2017;7:44612. [PMID: 28300213 DOI: 10.1038/srep44612] [Cited by in Crossref: 89] [Cited by in F6Publishing: 92] [Article Influence: 17.8] [Reference Citation Analysis]
187 Song K, Kwon H, Han C, Chen W, Zhang J, Ma W, Dash S, Gandhi CR, Wu T. Yes-Associated Protein in Kupffer Cells Enhances the Production of Proinflammatory Cytokines and Promotes the Development of Nonalcoholic Steatohepatitis. Hepatology. 2019;. [PMID: 31610032 DOI: 10.1002/hep.30990] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
188 Kumar S, Verma AK, Rani R, Sharma A, Wang J, Shah SA, Behari J, Salazar Gonzalez R, Kohli R, Gandhi CR. Hepatic Deficiency of Augmenter of Liver Regeneration Predisposes to Nonalcoholic Steatohepatitis and Fibrosis. Hepatology 2020;72:1586-604. [PMID: 32031683 DOI: 10.1002/hep.31167] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
189 Zhang Z, Li B, Meng X, Yao S, Jin L, Yang J, Wang J, Zhang H, Zhang Z, Cai D, Zhang Y, Ning G. Berberine prevents progression from hepatic steatosis to steatohepatitis and fibrosis by reducing endoplasmic reticulum stress. Sci Rep 2016;6:20848. [PMID: 26857750 DOI: 10.1038/srep20848] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 7.7] [Reference Citation Analysis]
190 Bian Z, Peng Y, You Z, Wang Q, Miao Q, Liu Y, Han X, Qiu D, Li Z, Ma X. CCN1 expression in hepatocytes contributes to macrophage infiltration in nonalcoholic fatty liver disease in mice. J Lipid Res. 2013;54:44-54. [PMID: 23071295 DOI: 10.1194/jlr.M026013] [Cited by in Crossref: 36] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
191 Chen YJ, Wallig MA, Jeffery EH. Dietary Broccoli Lessens Development of Fatty Liver and Liver Cancer in Mice Given Diethylnitrosamine and Fed a Western or Control Diet. J Nutr 2016;146:542-50. [PMID: 26865652 DOI: 10.3945/jn.115.228148] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 5.3] [Reference Citation Analysis]
192 Wu L, Li J, Feng J, Ji J, Yu Q, Li Y, Zheng Y, Dai W, Wu J, Guo C. Crosstalk between PPARs and gut microbiota in NAFLD. Biomed Pharmacother 2021;136:111255. [PMID: 33485064 DOI: 10.1016/j.biopha.2021.111255] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
193 Gantzel RH, Kjær MB, Laursen TL, Kazankov K, George J, Møller HJ, Grønbæk H. Macrophage Activation Markers, Soluble CD163 and Mannose Receptor, in Liver Fibrosis. Front Med (Lausanne) 2020;7:615599. [PMID: 33490096 DOI: 10.3389/fmed.2020.615599] [Reference Citation Analysis]
194 Zhong X, Liu H. Honokiol attenuates diet-induced non-alcoholic steatohepatitis by regulating macrophage polarization through activating peroxisome proliferator-activated receptor γ. J Gastroenterol Hepatol 2018;33:524-32. [PMID: 28670854 DOI: 10.1111/jgh.13853] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
195 Zhang S, Lu C, Das AK, Pasupulati AK, Menon RK. Abrogation of GH action in Kupffer cells results in increased hepatic CD36 expression and exaggerated nonalcoholic fatty liver disease. Growth Horm IGF Res 2018;42-43:74-9. [PMID: 30321786 DOI: 10.1016/j.ghir.2018.10.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
196 Alisi A, Cianfarani S, Manco M, Agostoni C, Nobili V. Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: pathogenetic role of genetic background and intrauterine environment. Ann Med. 2012;44:29-40. [PMID: 21355790 DOI: 10.3109/07853890.2010.547869] [Cited by in Crossref: 62] [Cited by in F6Publishing: 53] [Article Influence: 5.6] [Reference Citation Analysis]
197 Sahini N, Borlak J. Recent insights into the molecular pathophysiology of lipid droplet formation in hepatocytes. Prog Lipid Res. 2014;54:86-112. [PMID: 24607340 DOI: 10.1016/j.plipres.2014.02.002] [Cited by in Crossref: 63] [Cited by in F6Publishing: 59] [Article Influence: 7.9] [Reference Citation Analysis]
198 Yang CY, Chen JB, Tsai TF, Tsai YC, Tsai CY, Liang PH, Hsu TL, Wu CY, Netea MG, Wong CH, Hsieh SL. CLEC4F is an inducible C-type lectin in F4/80-positive cells and is involved in alpha-galactosylceramide presentation in liver. PLoS One 2013;8:e65070. [PMID: 23762286 DOI: 10.1371/journal.pone.0065070] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 5.6] [Reference Citation Analysis]
199 Tang T, Sui Y, Lian M, Li Z, Hua J. Pro-inflammatory activated Kupffer cells by lipids induce hepatic NKT cells deficiency through activation-induced cell death. PLoS One. 2013;8:e81949. [PMID: 24312613 DOI: 10.1371/journal.pone.0081949] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 4.2] [Reference Citation Analysis]
200 Wang L, Wu S, Cai M, Ma J, Li S, Li M, Xu Y, Wei L, Shang J. Comprehensive Study of Multiple Stages Progressing to Nonalcoholic Steatohepatitis with Subsequent Fibrosis in SD Rats. Int J Mol Sci 2017;18:E1681. [PMID: 28820447 DOI: 10.3390/ijms18081681] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
201 Miyazaki H, Sawada T, Kiyohira M, Yu Z, Nakamura K, Yasumoto Y, Kagawa Y, Ebrahimi M, Islam A, Sharifi K, Kawamura S, Kodama T, Yamamoto Y, Adachi Y, Tokuda N, Terai S, Sakaida I, Ishikawa T, Owada Y. Fatty acid binding protein 7 regulates phagocytosis and cytokine production in Kupffer cells during liver injury. Am J Pathol 2014;184:2505-15. [PMID: 25041855 DOI: 10.1016/j.ajpath.2014.05.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
202 Méndez-Sánchez N, Valencia-Rodríguez A, Coronel-Castillo C, Vera-Barajas A, Contreras-Carmona J, Ponciano-Rodríguez G, Zamora-Valdés D. The cellular pathways of liver fibrosis in non-alcoholic steatohepatitis. Ann Transl Med 2020;8:400. [PMID: 32355844 DOI: 10.21037/atm.2020.02.184] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
203 Chen K, Ma J, Jia X, Ai W, Ma Z, Pan Q. Advancing the understanding of NAFLD to hepatocellular carcinoma development: From experimental models to humans. Biochim Biophys Acta Rev Cancer. 2019;1871:117-125. [PMID: 30528647 DOI: 10.1016/j.bbcan.2018.11.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
204 Son G, Kremer M, Hines IN. Contribution of gut bacteria to liver pathobiology. Gastroenterol Res Pract. 2010;2010:453563. [PMID: 20706692 DOI: 10.1155/2010/453563] [Cited by in Crossref: 63] [Cited by in F6Publishing: 69] [Article Influence: 5.3] [Reference Citation Analysis]
205 Wu B, Xiao Z, Zhang W, Chen H, Liu H, Pan J, Cai X, Liang G, Zhou B, Shan X, Zhang Y. A novel resveratrol-curcumin hybrid, a19, attenuates high fat diet-induced nonalcoholic fatty liver disease. Biomedicine & Pharmacotherapy 2019;110:951-60. [DOI: 10.1016/j.biopha.2018.11.088] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
206 Ganesan M, Poluektova LY, Kharbanda KK, Osna NA. Liver as a target of human immunodeficiency virus infection. World J Gastroenterol 2018; 24(42): 4728-4737 [PMID: 30479460 DOI: 10.3748/wjg.v24.i42.4728] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
207 Meshkani R, Vakili S. Tissue resident macrophages: Key players in the pathogenesis of type 2 diabetes and its complications. Clin Chim Acta. 2016;462:77-89. [PMID: 27570063 DOI: 10.1016/j.cca.2016.08.015] [Cited by in Crossref: 63] [Cited by in F6Publishing: 61] [Article Influence: 10.5] [Reference Citation Analysis]
208 Tølbøl KS, Stierstorfer B, Rippmann JF, Veidal SS, Rigbolt KTG, Schönberger T, Gillum MP, Hansen HH, Vrang N, Jelsing J, Feigh M, Broermann A. Disease Progression and Pharmacological Intervention in a Nutrient-Deficient Rat Model of Nonalcoholic Steatohepatitis. Dig Dis Sci 2019;64:1238-56. [PMID: 30511198 DOI: 10.1007/s10620-018-5395-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
209 Yin Y, Wang Q, Qi M, Zhang C, Li Z, Zhang W. Ghrelin ameliorates nonalcoholic steatohepatitis induced by chronic low-grade inflammation via blockade of Kupffer cell M1 polarization. J Cell Physiol 2021;236:5121-33. [PMID: 33345314 DOI: 10.1002/jcp.30218] [Reference Citation Analysis]
210 Shan Z, Ju C. Hepatic Macrophages in Liver Injury. Front Immunol 2020;11:322. [PMID: 32362892 DOI: 10.3389/fimmu.2020.00322] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
211 Lee Y, Friedman SL. Fibrosis in the Liver. Development, Differentiation and Disease of the Para-Alimentary Tract. Elsevier; 2010. pp. 151-200. [DOI: 10.1016/b978-0-12-385233-5.00006-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
212 Liu W, Baker RD, Bhatia T, Zhu L, Baker SS. Pathogenesis of nonalcoholic steatohepatitis. Cell Mol Life Sci. 2016;73:1969-1987. [PMID: 26894897 DOI: 10.1007/s00018-016-2161-x] [Cited by in Crossref: 91] [Cited by in F6Publishing: 93] [Article Influence: 15.2] [Reference Citation Analysis]
213 Miura K, Seki E, Ohnishi H, Brenner DA. Role of toll-like receptors and their downstream molecules in the development of nonalcoholic Fatty liver disease. Gastroenterol Res Pract 2010;2010:362847. [PMID: 21274430 DOI: 10.1155/2010/362847] [Cited by in Crossref: 99] [Cited by in F6Publishing: 105] [Article Influence: 9.0] [Reference Citation Analysis]
214 Muriel P. The Liver. Liver Pathophysiology. Elsevier; 2017. pp. 3-22. [DOI: 10.1016/b978-0-12-804274-8.00001-1] [Cited by in Crossref: 10] [Article Influence: 2.0] [Reference Citation Analysis]
215 Sheng L, Jiang B, Rui L. Intracellular lipid content is a key intrinsic determinant for hepatocyte viability and metabolic and inflammatory states in mice. Am J Physiol Endocrinol Metab 2013;305:E1115-23. [PMID: 23982157 DOI: 10.1152/ajpendo.00401.2013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
216 Tonan T, Fujimoto K, Qayyum A, Morita Y, Nakashima O, Ono N, Kawahara A, Kage M, Hayabuchi N, Ueno T. CD14 expression and Kupffer cell dysfunction in non-alcoholic steatohepatitis: superparamagnetic iron oxide-magnetic resonance image and pathologic correlation. J Gastroenterol Hepatol. 2012;27:789-796. [PMID: 22188204 DOI: 10.1111/j.1440-1746.2011.07057.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
217 Scott C, Stokes R, Cha KM, Clouston A, Eslam M, Metwally M, Swarbrick MM, George J, Gunton JE. Myeloid cell deletion of Aryl hydrocarbon Receptor Nuclear Translocator (ARNT) induces non-alcoholic steatohepatitis. PLoS One. 2019;14:e0225332. [PMID: 31800592 DOI: 10.1371/journal.pone.0225332] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
218 Kim MY. [The Progression of Liver Fibrosis in Non-alcoholic Fatty Liver Disease]. Korean J Gastroenterol 2017;69:341-7. [PMID: 28637102 DOI: 10.4166/kjg.2017.69.6.341] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
219 Pereira RM, Botezelli JD, da Cruz Rodrigues KC, Mekary RA, Cintra DE, Pauli JR, da Silva ASR, Ropelle ER, de Moura LP. Fructose Consumption in the Development of Obesity and the Effects of Different Protocols of Physical Exercise on the Hepatic Metabolism. Nutrients 2017;9:E405. [PMID: 28425939 DOI: 10.3390/nu9040405] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 8.4] [Reference Citation Analysis]
220 Wiernsperger N. Hepatic function and the cardiometabolic syndrome. Diabetes Metab Syndr Obes. 2013;6:379-388. [PMID: 24143116 DOI: 10.2147/dmso.s51145] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
221 Jourdan T, Nicoloro SM, Zhou Z, Shen Y, Liu J, Coffey NJ, Cinar R, Godlewski G, Gao B, Aouadi M, Czech MP, Kunos G. Decreasing CB1 receptor signaling in Kupffer cells improves insulin sensitivity in obese mice. Mol Metab 2017;6:1517-28. [PMID: 29107297 DOI: 10.1016/j.molmet.2017.08.011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
222 Harmon RC, Tiniakos DG, Argo CK. Inflammation in nonalcoholic steatohepatitis. Expert Review of Gastroenterology & Hepatology 2014;5:189-200. [DOI: 10.1586/egh.11.21] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 7.0] [Reference Citation Analysis]
223 Stepanov V, Stankov K, Mikov M. The bile acid membrane receptor TGR5: a novel pharmacological target in metabolic, inflammatory and neoplastic disorders. J Recept Signal Transduct Res. 2013;33:213-223. [PMID: 23782454 DOI: 10.3109/10799893.2013.802805] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 5.3] [Reference Citation Analysis]
224 Gore E, Bigaeva E, Oldenburger A, Jansen YJM, Schuppan D, Boersema M, Rippmann JF, Broermann A, Olinga P. Investigating fibrosis and inflammation in an ex vivo NASH murine model. Am J Physiol Gastrointest Liver Physiol 2020;318:G336-51. [PMID: 31905025 DOI: 10.1152/ajpgi.00209.2019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
225 Orci LA, Kreutzfeldt M, Goossens N, Rubbia-Brandt L, Slits F, Hammad K, Delaune V, Oldani G, Negro F, Clément S, Gonelle-Gispert C, Buhler LH, Toso C, Lacotte S. Tolerogenic properties of liver macrophages in non-alcoholic steatohepatitis. Liver Int 2020;40:609-21. [PMID: 31872499 DOI: 10.1111/liv.14336] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
226 Tian H, Liu C, Zou X, Wu W, Zhang C, Yuan D. MiRNA-194 Regulates Palmitic Acid-Induced Toll-Like Receptor 4 Inflammatory Responses in THP-1 Cells. Nutrients 2015;7:3483-96. [PMID: 25984739 DOI: 10.3390/nu7053483] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 6.0] [Reference Citation Analysis]
227 Xu L, Liu W, Bai F, Xu Y, Liang X, Ma C, Gao L. Hepatic Macrophage as a Key Player in Fatty Liver Disease. Front Immunol 2021;12:708978. [PMID: 34956171 DOI: 10.3389/fimmu.2021.708978] [Reference Citation Analysis]
228 Dixon LJ, Barnes M, Tang H, Pritchard MT, Nagy LE. Kupffer cells in the liver. Compr Physiol. 2013;3:785-797. [PMID: 23720329 DOI: 10.1002/cphy.c120026] [Cited by in Crossref: 90] [Cited by in F6Publishing: 171] [Article Influence: 10.0] [Reference Citation Analysis]
229 López-Navarrete G, Ramos-Martínez E, Suárez-Álvarez K, Aguirre-García J, Ledezma-Soto Y, León-Cabrera S, Gudiño-Zayas M, Guzmán C, Gutiérrez-Reyes G, Hernández-Ruíz J, Camacho-Arroyo I, Robles-Díaz G, Kershenobich D, Terrazas LI, Escobedo G. Th2-associated alternative Kupffer cell activation promotes liver fibrosis without inducing local inflammation. Int J Biol Sci 2011;7:1273-86. [PMID: 22110380 DOI: 10.7150/ijbs.7.1273] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
230 Kamada Y, Kiso S, Yoshida Y, Chatani N, Kizu T, Hamano M, Egawa M, Takemura T, Ezaki H, Furuta K, Hayashi N, Takehara T. Pitavastatin ameliorated the progression of steatohepatitis in ovariectomized mice fed a high fat and high cholesterol diet. Hepatol Res 2013;43:401-12. [PMID: 22971151 DOI: 10.1111/j.1872-034X.2012.01082.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
231 Rensen SS, Bieghs V, Xanthoulea S, Arfianti E, Bakker JA, Shiri-Sverdlov R, Hofker MH, Greve JW, Buurman WA. Neutrophil-derived myeloperoxidase aggravates non-alcoholic steatohepatitis in low-density lipoprotein receptor-deficient mice. PLoS One. 2012;7:e52411. [PMID: 23285030 DOI: 10.1371/journal.pone.0052411] [Cited by in Crossref: 63] [Cited by in F6Publishing: 68] [Article Influence: 6.3] [Reference Citation Analysis]
232 Deng W, Wang X, Xiao J, Chen K, Zhou H, Shen D, Li H, Tang Q. Loss of regulator of G protein signaling 5 exacerbates obesity, hepatic steatosis, inflammation and insulin resistance. PLoS One 2012;7:e30256. [PMID: 22272317 DOI: 10.1371/journal.pone.0030256] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
233 Pei C, Wu CZ, Hsieh CH, Chang JB, Liang YJ, Chen YL, Pei D, Lin JD. Protective Effect of Hepatitis B Against Metabolic Syndrome in Patients with Nonalcoholic Fatty Liver Disease But Not in Normal Individuals. Metab Syndr Relat Disord 2019;17:458-64. [PMID: 31545133 DOI: 10.1089/met.2019.0032] [Reference Citation Analysis]
234 Davidson MD, Ballinger KR, Khetani SR. Long-term exposure to abnormal glucose levels alters drug metabolism pathways and insulin sensitivity in primary human hepatocytes. Sci Rep 2016;6:28178. [PMID: 27312339 DOI: 10.1038/srep28178] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 7.0] [Reference Citation Analysis]
235 De Minicis S, Seki E, Paik YH, Osterreicher CH, Kodama Y, Kluwe J, Torozzi L, Miyai K, Benedetti A, Schwabe RF. Role and cellular source of nicotinamide adenine dinucleotide phosphate oxidase in hepatic fibrosis. Hepatology. 2010;52:1420-1430. [PMID: 20690191 DOI: 10.1002/hep.23804] [Cited by in Crossref: 60] [Cited by in F6Publishing: 63] [Article Influence: 5.0] [Reference Citation Analysis]
236 Raszeja-Wyszomirska J, Kurzawski G, Lawniczak M, Miezynska-Kurtycz J, Lubinski J. Nonalcoholic fatty liver disease and HFE gene mutations: A Polish study. World J Gastroenterol 2010; 16(20): 2531-2536 [PMID: 20503453 DOI: 10.3748/wjg.v16.i20.2531] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
237 Tirosh O. Hypoxic Signaling and Cholesterol Lipotoxicity in Fatty Liver Disease Progression. Oxid Med Cell Longev 2018;2018:2548154. [PMID: 29955245 DOI: 10.1155/2018/2548154] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 8.3] [Reference Citation Analysis]
238 Cai C, Zhu X, Li P, Li J, Gong J, Shen W, He K. NLRP3 Deletion Inhibits the Non-alcoholic Steatohepatitis Development and Inflammation in Kupffer Cells Induced by Palmitic Acid. Inflammation 2017;40:1875-83. [DOI: 10.1007/s10753-017-0628-z] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 6.8] [Reference Citation Analysis]
239 Sohn W, Jun DW, Lee KN, Lee HL, Lee OY, Choi HS, Yoon BC. Lactobacillus paracasei Induces M2-Dominant Kupffer Cell Polarization in a Mouse Model of Nonalcoholic Steatohepatitis. Dig Dis Sci 2015;60:3340-50. [PMID: 26143342 DOI: 10.1007/s10620-015-3770-1] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
240 Balmer ML, Slack E, de Gottardi A, Lawson MA, Hapfelmeier S, Miele L, Grieco A, Van Vlierberghe H, Fahrner R, Patuto N, Bernsmeier C, Ronchi F, Wyss M, Stroka D, Dickgreber N, Heim MH, McCoy KD, Macpherson AJ. The liver may act as a firewall mediating mutualism between the host and its gut commensal microbiota. Sci Transl Med. 2014;6:237ra66. [PMID: 24848256 DOI: 10.1126/scitranslmed.3008618] [Cited by in Crossref: 235] [Cited by in F6Publishing: 219] [Article Influence: 29.4] [Reference Citation Analysis]
241 Hasan AU, Rahman A, Kobori H. Interactions between Host PPARs and Gut Microbiota in Health and Disease. Int J Mol Sci 2019;20:E387. [PMID: 30658440 DOI: 10.3390/ijms20020387] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
242 Hammarstedt A, Gogg S, Hedjazifar S, Nerstedt A, Smith U. Impaired Adipogenesis and Dysfunctional Adipose Tissue in Human Hypertrophic Obesity. Physiol Rev. 2018;98:1911-1941. [PMID: 30067159 DOI: 10.1152/physrev.00034.2017] [Cited by in Crossref: 108] [Cited by in F6Publishing: 100] [Article Influence: 36.0] [Reference Citation Analysis]
243 Wang XA, Zhang R, Jiang D, Deng W, Zhang S, Deng S, Zhong J, Wang T, Zhu LH, Yang L, Hong S, Guo S, Chen K, Zhang XF, She Z, Chen Y, Yang Q, Zhang XD, Li H. Interferon regulatory factor 9 protects against hepatic insulin resistance and steatosis in male mice. Hepatology 2013;58:603-16. [PMID: 23471885 DOI: 10.1002/hep.26368] [Cited by in Crossref: 58] [Cited by in F6Publishing: 58] [Article Influence: 6.4] [Reference Citation Analysis]
244 Rui L. Energy metabolism in the liver. Compr Physiol. 2014;4:177-197. [PMID: 24692138 DOI: 10.1002/cphy.c130024] [Cited by in Crossref: 700] [Cited by in F6Publishing: 681] [Article Influence: 87.5] [Reference Citation Analysis]
245 Qin H, Xu D, Yang S. Dextran-coated Fe 3 O 4 magnetic nanoparticles as a contrast agent in thermoacoustic tomography for hepatocellular carcinoma detection. J Phys : Conf Ser 2011;277:012028. [DOI: 10.1088/1742-6596/277/1/012028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
246 Tapia GS, González-mañán D, D’espessailles A, Dossi CG. <em>n-3</em> LCPUFA in the reversal of hepatic steatosis: the role of ACOX and CAT-1. Grasas y Aceites 2016;67:e134. [DOI: 10.3989/gya.0886152] [Reference Citation Analysis]
247 Fukushima H, Yamashina S, Arakawa A, Taniguchi G, Aoyama T, Uchiyama A, Kon K, Ikejima K, Watanabe S. Formation of p62-positive inclusion body is associated with macrophage polarization in non-alcoholic fatty liver disease: Aggregation of p62 and macrophages. Hepatol Res 2018;48:757-67. [DOI: 10.1111/hepr.13071] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
248 Han P, Sun D, Yang J. Interaction between periodontitis and liver diseases. Biomed Rep 2016;5:267-76. [PMID: 27588170 DOI: 10.3892/br.2016.718] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
249 Zhu R, Wang Y, Zhang L, Guo Q. Oxidative stress and liver disease: Oxidative stress and liver disease. Hepatology Research 2012;42:741-9. [DOI: 10.1111/j.1872-034x.2012.00996.x] [Cited by in Crossref: 122] [Cited by in F6Publishing: 49] [Article Influence: 12.2] [Reference Citation Analysis]
250 Kim JJ, Sears DD. TLR4 and Insulin Resistance. Gastroenterol Res Pract 2010;2010:212563. [PMID: 20814545 DOI: 10.1155/2010/212563] [Cited by in Crossref: 95] [Cited by in F6Publishing: 98] [Article Influence: 7.9] [Reference Citation Analysis]
251 Li X, Huang W, Gu J, Du X, Lei L, Yuan X, Sun G, Wang Z, Li X, Liu G. SREBP-1c overactivates ROS-mediated hepatic NF-κB inflammatory pathway in dairy cows with fatty liver. Cell Signal 2015;27:2099-109. [PMID: 26189441 DOI: 10.1016/j.cellsig.2015.07.011] [Cited by in Crossref: 76] [Cited by in F6Publishing: 72] [Article Influence: 10.9] [Reference Citation Analysis]
252 Shah RA, Kowdley KV. Serum ferritin as a biomarker for NAFLD: ready for prime time? Hepatol Int 2019;13:110-2. [PMID: 30739262 DOI: 10.1007/s12072-019-09934-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
253 Skat-Rørdam J, Højland Ipsen D, Lykkesfeldt J, Tveden-Nyborg P. A role of peroxisome proliferator-activated receptor γ in non-alcoholic fatty liver disease. Basic Clin Pharmacol Toxicol 2019;124:528-37. [PMID: 30561132 DOI: 10.1111/bcpt.13190] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 11.7] [Reference Citation Analysis]
254 Fan G, Li Y, Chen J, Zong Y, Yang X. DHA/AA alleviates LPS-induced Kupffer cells pyroptosis via GPR120 interaction with NLRP3 to inhibit inflammasome complexes assembly. Cell Death Dis 2021;12:73. [PMID: 33436541 DOI: 10.1038/s41419-020-03347-3] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
255 Wu H, Ni X, Xu Q, Wang Q, Li X, Hua J. Regulation of lipid‐induced macrophage polarization through modulating peroxisome proliferator‐activated receptor‐gamma activity affects hepatic lipid metabolism via a Toll‐like receptor 4/NF‐κB signaling pathway. Journal of Gastroenterology and Hepatology 2020;35:1998-2008. [DOI: 10.1111/jgh.15025] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
256 Aparicio-Vergara M, Tencerova M, Morgantini C, Barreby E, Aouadi M. Isolation of Kupffer Cells and Hepatocytes from a Single Mouse Liver. Methods Mol Biol 2017;1639:161-71. [PMID: 28752456 DOI: 10.1007/978-1-4939-7163-3_16] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 7.3] [Reference Citation Analysis]
257 Wu D, Zhang M, Xu S, Wu K, Wang N, Wang Y, Wu J, Lu G, Gong W, Ding Y, Xiao W. Nonalcoholic Fatty Liver Disease Aggravated the Severity of Acute Pancreatitis in Patients. Biomed Res Int 2019;2019:9583790. [PMID: 30805370 DOI: 10.1155/2019/9583790] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
258 Frasinariu OE, Ceccarelli S, Alisi A, Moraru E, Nobili V. Gut-liver axis and fibrosis in nonalcoholic fatty liver disease: an input for novel therapies. Dig Liver Dis. 2013;45:543-551. [PMID: 23280158 DOI: 10.1016/j.dld.2012.11.010] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 5.9] [Reference Citation Analysis]
259 Nobili V, Sanyal AJ. Treatment of nonalcoholic fatty liver disease in adults and children: a closer look at the arsenal. J Gastroenterol 2012;47:29-36. [PMID: 21983927 DOI: 10.1007/s00535-011-0467-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
260 Houben T, Brandsma E, Walenbergh SMA, Hofker MH, Shiri-Sverdlov R. Oxidized LDL at the crossroads of immunity in non-alcoholic steatohepatitis. Biochim Biophys Acta Mol Cell Biol Lipids 2017;1862:416-29. [PMID: 27472963 DOI: 10.1016/j.bbalip.2016.07.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
261 Kermanizadeh A, Brown DM, Moritz W, Stone V. The importance of inter-individual Kupffer cell variability in the governance of hepatic toxicity in a 3D primary human liver microtissue model. Sci Rep 2019;9:7295. [PMID: 31086251 DOI: 10.1038/s41598-019-43870-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
262 Vigerust NF, Bjørndal B, Bohov P, Brattelid T, Svardal A, Berge RK. Krill oil versus fish oil in modulation of inflammation and lipid metabolism in mice transgenic for TNF-α. Eur J Nutr 2013;52:1315-25. [PMID: 22923017 DOI: 10.1007/s00394-012-0441-2] [Cited by in Crossref: 70] [Cited by in F6Publishing: 64] [Article Influence: 7.0] [Reference Citation Analysis]
263 Lu S, Natarajan SK, Mott JL, Kharbanda KK, Harrison-Findik DD. Ceramide Induces Human Hepcidin Gene Transcription through JAK/STAT3 Pathway. PLoS One 2016;11:e0147474. [PMID: 26807955 DOI: 10.1371/journal.pone.0147474] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
264 Jorgačević B, Mladenović D, Ninković M, Prokić V, Stanković M, Aleksić V, Cerović I, Vukićević RJ, Vučević D, Stanković M, Radosavljević T. Dynamics of oxidative/nitrosative stress in mice with methionine–choline-deficient diet-induced nonalcoholic fatty liver disease. Hum Exp Toxicol 2014;33:701-9. [DOI: 10.1177/0960327113506723] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
265 Rehman K, Akash MS. Mechanisms of inflammatory responses and development of insulin resistance: how are they interlinked? J Biomed Sci 2016;23:87. [PMID: 27912756 DOI: 10.1186/s12929-016-0303-y] [Cited by in Crossref: 150] [Cited by in F6Publishing: 140] [Article Influence: 25.0] [Reference Citation Analysis]
266 Kitson MT, Roberts SK. D-livering the message: the importance of vitamin D status in chronic liver disease. J Hepatol. 2012;57:897-909. [PMID: 22634121 DOI: 10.1016/j.jhep.2012.04.033] [Cited by in Crossref: 134] [Cited by in F6Publishing: 121] [Article Influence: 13.4] [Reference Citation Analysis]
267 Buonocore C, Alipour M, Omri A, Pucaj K, Smith MG, Suntres ZE. Treatment of ricin A-chain-induced hepatotoxicity with liposome-encapsulated N-acetylcysteine. Journal of Drug Targeting 2011;19:821-9. [DOI: 10.3109/1061186x.2011.582645] [Cited by in Crossref: 15] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
268 Oliveira-junior MC, Monteiro AS, Leal-junior ECP, Munin E, Osório RAL, Ribeiro W, Vieira RP. Low-level Laser Therapy Ameliorates CCl 4 -induced Liver Cirrhosis in Rats. Photochem Photobiol 2013;89:173-8. [DOI: 10.1111/j.1751-1097.2012.01211.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
269 Finelli C, Tarantino G. What is the role of adiponectin in obesity related non-alcoholic fatty liver disease? World J Gastroenterol 2013; 19(6): 802-812 [PMID: 23430039 DOI: 10.3748/wjg.v19.i6.802] [Cited by in CrossRef: 104] [Cited by in F6Publishing: 107] [Article Influence: 11.6] [Reference Citation Analysis]
270 Ferreyra Solari NE, Inzaugarat ME, Baz P, De Matteo E, Lezama C, Galoppo M, Galoppo C, Cherñavsky AC. The role of innate cells is coupled to a Th1-polarized immune response in pediatric nonalcoholic steatohepatitis. J Clin Immunol 2012;32:611-21. [PMID: 22228550 DOI: 10.1007/s10875-011-9635-2] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
271 Peverill W, Powell LW, Skoien R. Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation. Int J Mol Sci 2014;15:8591-638. [PMID: 24830559 DOI: 10.3390/ijms15058591] [Cited by in Crossref: 178] [Cited by in F6Publishing: 164] [Article Influence: 22.3] [Reference Citation Analysis]
272 Lelis DDF, Andrade JMO, Almenara CCP, Broseguini-filho GB, Mill JG, Baldo MP. High fructose intake and the route towards cardiometabolic diseases. Life Sciences 2020;259:118235. [DOI: 10.1016/j.lfs.2020.118235] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
273 Shi Y, Su W, Zhang L, Shi C, Zhou J, Wang P, Wang H, Shi X, Wei S, Wang Q, Auwerx J, Schoonjans K, Yu Y, Pan R, Zhou H, Lu L. TGR5 Regulates Macrophage Inflammation in Nonalcoholic Steatohepatitis by Modulating NLRP3 Inflammasome Activation. Front Immunol 2020;11:609060. [PMID: 33692776 DOI: 10.3389/fimmu.2020.609060] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
274 Johnson AR, Milner JJ, Makowski L. The inflammation highway: metabolism accelerates inflammatory traffic in obesity. Immunol Rev 2012;249:218-38. [PMID: 22889225 DOI: 10.1111/j.1600-065X.2012.01151.x] [Cited by in Crossref: 350] [Cited by in F6Publishing: 199] [Article Influence: 38.9] [Reference Citation Analysis]
275 de Andrade KQ, Moura FA, dos Santos JM, de Araújo OR, de Farias Santos JC, Goulart MO. Oxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-Acetylcysteine. Int J Mol Sci 2015;16:30269-308. [PMID: 26694382 DOI: 10.3390/ijms161226225] [Cited by in Crossref: 115] [Cited by in F6Publishing: 97] [Article Influence: 16.4] [Reference Citation Analysis]
276 Graupera I, Coll M, Pose E, Elia C, Piano S, Solà E, Blaya D, Huelin P, Solé C, Moreira R, de Prada G, Fabrellas N, Juanola A, Morales-Ruiz M, Sancho-Bru P, Villanueva C, Ginès P. Adipocyte Fatty-Acid Binding Protein is Overexpressed in Cirrhosis and Correlates with Clinical Outcomes. Sci Rep 2017;7:1829. [PMID: 28500294 DOI: 10.1038/s41598-017-01709-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
277 Tencerova M. Glucan-Encapsulated siRNA Particles (GeRPs) for Specific Gene Silencing in Kupffer Cells in Mouse Liver. Methods Mol Biol 2020;2164:65-73. [PMID: 32607884 DOI: 10.1007/978-1-0716-0704-6_8] [Reference Citation Analysis]
278 Zwolak A, Słabczyńska O, Semeniuk J, Daniluk J, Szuster-Ciesielska A. Metformin Changes the Relationship between Blood Monocyte Toll-Like Receptor 4 Levels and Nonalcoholic Fatty Liver Disease-Ex Vivo Studies. PLoS One 2016;11:e0150233. [PMID: 26930651 DOI: 10.1371/journal.pone.0150233] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
279 Nobili V, Svegliati-baroni G, Alisi A, Miele L, Valenti L, Vajro P. A 360-degree overview of paediatric NAFLD: Recent insights. Journal of Hepatology 2013;58:1218-29. [DOI: 10.1016/j.jhep.2012.12.003] [Cited by in Crossref: 106] [Cited by in F6Publishing: 99] [Article Influence: 11.8] [Reference Citation Analysis]
280 Jager J, Aparicio-Vergara M, Aouadi M. Liver innate immune cells and insulin resistance: the multiple facets of Kupffer cells. J Intern Med 2016;280:209-20. [PMID: 26864622 DOI: 10.1111/joim.12483] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 8.3] [Reference Citation Analysis]
281 Revie D, Salahuddin SZ. Role of macrophages and monocytes in hepatitis C virus infections. World J Gastroenterol 2014; 20(11): 2777-2784 [PMID: 24659871 DOI: 10.3748/wjg.v20.i11.2777] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
282 Lake AD, Hardwick RN, Leamon CP, Low PS, Cherrington NJ. Folate receptor-beta expression as a diagnostic target in human & rodent nonalcoholic steatohepatitis. Toxicol Appl Pharmacol 2019;368:49-54. [PMID: 30794826 DOI: 10.1016/j.taap.2019.02.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
283 Robert O, Boujedidi H, Bigorgne A, Ferrere G, Voican CS, Vettorazzi S, Tuckermann JP, Bouchet-Delbos L, Tran T, Hemon P, Puchois V, Dagher I, Douard R, Gaudin F, Gary-Gouy H, Capel F, Durand-Gasselin I, Prévot S, Rousset S, Naveau S, Godot V, Emilie D, Lombès M, Perlemuter G, Cassard AM. Decreased expression of the glucocorticoid receptor-GILZ pathway in Kupffer cells promotes liver inflammation in obese mice. J Hepatol 2016;64:916-24. [PMID: 26639395 DOI: 10.1016/j.jhep.2015.11.023] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
284 Mu Q, Wang H, Tong L, Fang Q, Xiang M, Han L, Jin L, Yang J, Qian Z, Ning G, Zhang Y, Zhang Z. Betulinic acid improves nonalcoholic fatty liver disease through YY1/FAS signaling pathway. FASEB J 2020;34:13033-48. [PMID: 32777136 DOI: 10.1096/fj.202000546R] [Reference Citation Analysis]
285 Alisi A, Carsetti R, Nobili V. Pathogen- or damage-associated molecular patterns during nonalcoholic fatty liver disease development. Hepatology 2011;54:1500-2. [DOI: 10.1002/hep.24611] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.7] [Reference Citation Analysis]
286 Jin R, Willment A, Patel SS, Sun X, Song M, Mannery YO, Kosters A, McClain CJ, Vos MB. Fructose induced endotoxemia in pediatric nonalcoholic Fatty liver disease. Int J Hepatol. 2014;2014:560620. [PMID: 25328713 DOI: 10.1155/2014/560620] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 5.5] [Reference Citation Analysis]
287 Zhang J, Chen W, Fang L, Li Q, Zhang X, Zhang H, Guan Q, Zhao R, Yang C, Jing F. Increased intermediate monocyte fraction in peripheral blood is associated with nonalcoholic fatty liver disease. Wien Klin Wochenschr 2018;130:390-7. [PMID: 29845362 DOI: 10.1007/s00508-018-1348-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
288 Xia J, Yuan J, Xin L, Zhang Y, Kong S, Chen Y, Yang S, Li K. Transcriptome analysis on the inflammatory cell infiltration of nonalcoholic steatohepatitis in bama minipigs induced by a long-term high-fat, high-sucrose diet. PLoS One 2014;9:e113724. [PMID: 25415189 DOI: 10.1371/journal.pone.0113724] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
289 Maeda H, Ishima Y, Saruwatari J, Mizuta Y, Minayoshi Y, Ichimizu S, Yanagisawa H, Nagasaki T, Yasuda K, Oshiro S, Taura M, McConnell MJ, Oniki K, Sonoda K, Wakayama T, Kinoshita M, Shuto T, Kai H, Tanaka M, Sasaki Y, Iwakiri Y, Otagiri M, Watanabe H, Maruyama T. Nitric oxide facilitates the targeting Kupffer cells of a nano-antioxidant for the treatment of NASH. J Control Release 2021;341:457-74. [PMID: 34856227 DOI: 10.1016/j.jconrel.2021.11.039] [Reference Citation Analysis]
290 Gasparotto J, Chaves PR, da Boit Martinello K, da Rosa-siva HT, Bortolin RC, Silva LFO, Rabelo TK, da Silva J, da Silva FR, Nordin AP, Soares K, Borges MS, Gelain DP, Moreira JCF. Obese rats are more vulnerable to inflammation, genotoxicity and oxidative stress induced by coal dust inhalation than non-obese rats. Ecotoxicology and Environmental Safety 2018;165:44-51. [DOI: 10.1016/j.ecoenv.2018.08.097] [Cited by in Crossref: 39] [Cited by in F6Publishing: 25] [Article Influence: 9.8] [Reference Citation Analysis]
291 Liu J, Zhuang Z, Bian D, Ma X, Xun Y, Yang W, Luo Y, Liu Y, Jia L, Wang Y, Zhu M, Ye D, Zhou G, Lou G, Shi J. Toll-like receptor-4 signalling in the progression of non-alcoholic fatty liver disease induced by high-fat and high-fructose diet in mice. Clin Exp Pharmacol Physiol 2014;41:482-8. [DOI: 10.1111/1440-1681.12241] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 5.4] [Reference Citation Analysis]
292 Sawano T, Shimizu T, Yamada T, Nanashima N, Miura T, Morohashi S, Kudo D, Hui FM, Kijima H, Hakamada K, Tsuchida S. Fatty acid synthase-positive hepatocytes and subsequent steatosis in rat livers by irinotecan. Oncol Rep 2015;33:2151-60. [PMID: 25708528 DOI: 10.3892/or.2015.3814] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
293 Yang QH, Xu YJ, Liu YZ, Liang YJ, Feng GF, Zhang YP, Xing HJ, Yan HZ, Li YY. Effects of Chaihu-Shugan-San and Shen-Ling-Bai-Zhu-San on p38 MAPK Pathway in Kupffer Cells of Nonalcoholic Steatohepatitis. Evid Based Complement Alternat Med 2014;2014:671013. [PMID: 24795769 DOI: 10.1155/2014/671013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
294 Clària J, González-Périz A, López-Vicario C, Rius B, Titos E. New insights into the role of macrophages in adipose tissue inflammation and Fatty liver disease: modulation by endogenous omega-3 Fatty Acid-derived lipid mediators. Front Immunol 2011;2:49. [PMID: 22566839 DOI: 10.3389/fimmu.2011.00049] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
295 Peng Y, Li JZ, You M, Murr MM. Roux-en-Y gastric bypass improves glucose homeostasis, reduces oxidative stress and inflammation in livers of obese rats and in Kupffer cells via an AMPK-dependent pathway. Surgery 2017;162:59-67. [PMID: 28291540 DOI: 10.1016/j.surg.2017.01.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
296 Lepreux S, Villeneuve J, Dewitte A, Bérard AM, Desmoulière A, Ripoche J. CD40 signaling and hepatic steatosis: Unanticipated links. Clin Res Hepatol Gastroenterol 2017;41:357-69. [PMID: 27989689 DOI: 10.1016/j.clinre.2016.11.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
297 Gioiello A, Rosatelli E, Nuti R, Macchiarulo A, Pellicciari R. Patented TGR5 modulators: a review (2006 - present). Expert Opin Ther Pat 2012;22:1399-414. [PMID: 23039746 DOI: 10.1517/13543776.2012.733000] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 3.5] [Reference Citation Analysis]
298 Mccarty MF. Full-spectrum antioxidant therapy featuring astaxanthin coupled with lipoprivic strategies and salsalate for management of non-alcoholic fatty liver disease. Medical Hypotheses 2011;77:550-6. [DOI: 10.1016/j.mehy.2011.06.029] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
299 Bessone F, Razori MV, Roma MG. Molecular pathways of nonalcoholic fatty liver disease development and progression. Cell Mol Life Sci. 2019;76:99-128. [PMID: 30343320 DOI: 10.1007/s00018-018-2947-0] [Cited by in Crossref: 109] [Cited by in F6Publishing: 118] [Article Influence: 27.3] [Reference Citation Analysis]
300 Sutter AG, Palanisamy AP, Ellet JD, Schmidt MG, Schnellmann RG, Chavin KD. Intereukin-10 and Kupffer cells protect steatotic mice livers from ischemia-reperfusion injury. Eur Cytokine Netw. 2014;25:69-76. [PMID: 25679269 DOI: 10.1684/ecn.2015.0359] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
301 Xu L, Nagata N, Ota T. Impact of Glucoraphanin-Mediated Activation of Nrf2 on Non-Alcoholic Fatty Liver Disease with a Focus on Mitochondrial Dysfunction. Int J Mol Sci 2019;20:E5920. [PMID: 31775341 DOI: 10.3390/ijms20235920] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
302 Kitani H, Sakuma C, Takenouchi T, Sato M, Yoshioka M, Yamanaka N. Establishment of c-myc-immortalized Kupffer cell line from a C57BL/6 mouse strain. Results Immunol 2014;4:68-74. [PMID: 25379377 DOI: 10.1016/j.rinim.2014.08.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
303 Zöller M, Jung T. The Colorectal Cancer Initiating Cell: Markers and Their Role in Liver Metastasis. In: Brodt P, editor. Liver Metastasis: Biology and Clinical Management. Dordrecht: Springer Netherlands; 2011. pp. 89-127. [DOI: 10.1007/978-94-007-0292-9_4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
304 Akiyama K, Warabi E, Okada K, Yanagawa T, Ishii T, Kose K, Tokushige K, Ishige K, Mizokami Y, Yamagata K, Onizawa K, Ariizumi SI, Yamamoto M, Shoda J. Deletion of both p62 and Nrf2 spontaneously results in the development of nonalcoholic steatohepatitis. Exp Anim 2018;67:201-18. [PMID: 29276215 DOI: 10.1538/expanim.17-0112] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]